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The genetic code underlying protein synthesis is a canonical example
of a degenerate biological system. Degeneracies in physical and bio-
logical systems can be lifted by external perturbations thus allowing
degenerate systems to exhibit a wide range of behaviors. Here we
show that the degeneracy of the genetic code is lifted by environ-
mental perturbations to regulate protein levels in living cells. By
measuring protein synthesis rates from a synthetic reporter library in
Escherichia coli, we find that environmental perturbations, such as
reduction of cognate amino acid supply, lift the degeneracy of the
genetic code by splitting codon families into a hierarchy of robust
and sensitive synonymous codons. Rates of protein synthesis asso-
ciated with robust codons are up to hundred-fold higher than those
associated with sensitive codons under these conditions. We find
that the observed hierarchy between synonymous codons is not de-
termined by usual rules associated with tRNA abundance and codon
usage. Rather, competition among tRNA isoacceptors for aminoa-
cylation underlies the robustness of protein synthesis. Remarkably,
the hierarchy established using the synthetic library also explains the
measured robustness of synthesis for endogenous proteins in E. coli.
We further found that the same hierarchy is reflected in the fit-
ness cost of synonymous mutations in amino acid biosynthesis genes
and in the transcriptional control of sigma factor genes. Our study
reveals that the degeneracy of the genetic code can be lifted by envi-
ronmental perturbations, and it suggests that organisms can exploit
degeneracy lifting as a general strategy to adapt protein synthesis
to their environment.
Abbreviations: AA, amino acid; CRI, codon robustness index
Degeneracy, the occurrence of distinct states that sharea common function, is a ubiquitous property of physi-
cal and biological systems [1, 2, 3]. Examples of degenerate
systems include atomic spectra [4], condensed matter [5], the
nervous system [2] and the genetic code [6, 7]. Degeneracy in
physical systems is often associated with underlying symme-
tries [1], and in biological systems with error-minimization,
evolvability, and robustness against perturbations [8]. Degen-
erate states that are indistinguishable under normal condi-
tions can exhibit distinct properties under the action of ex-
ternal perturbations [1]. This effect, called degeneracy lifting,
allows degenerate systems to exhibit a wide range of behaviors
depending on the environmental context [2]. The genetic code
governing protein synthesis is a highly degenerate system since
18 of the 20 amino acids have multiple synonymous codons
and 10 of the 20 amino acids are aminoacylated (charged)
onto multiple tRNA isoacceptors. Protein synthesis rates in
living cells respond to diverse environmental perturbations,
which raises the question of whether any of these perturba-
tions modulates protein levels by lifting the degeneracy of the
genetic code. Previous experiments found that both the con-
centration of charged tRNAs as well as the occupancy of ri-
bosomes on synonymous codons undergo significant changes
upon nutrient limitation [9, 10, 60]. Yet whether such environ-
mental perturbations lift the degeneracy of the genetic code by
modulating the expression level of proteins is unknown. Here,
we propose to use amino acid limitation in the bacterium Es-
cherichia coli as a model system to investigate whether the
degeneracy of the genetic code can be lifted by environmen-
tal perturbations, and how degeneracy lifting could provide a
general strategy to adapt protein synthesis to environmental
changes.
Results
Degeneracy lifting upon amino acid limitation.We considered
synonymous codons for seven amino acids: Leu, Arg, Ser, Pro,
Ile, Gln, and Phe. This set of seven amino acids is representa-
tive of the degeneracy of the genetic code, in that it includes
six-, four-, three- and two-fold degenerate codon families. We
constructed a library of 29 yellow fluorescent protein (yfp)
gene variants, each of which had between six and eight syn-
onymous mutations for one of the seven amino acids (Fig. 1A).
In this library, we designed each yfp variant to characterize the
effect of one specific codon on protein synthesis. We expressed
the yfp variants constitutively at low gene dosage (2 copies /
chromosome, Fig. 1B) in E. coli strains that were auxotrophic
for one or more amino acids. We monitored growth and YFP
synthesis in these strains during amino acid-rich growth as
well as during limitation for each of the seven amino acids
(Methods).
During amino acid-rich growth, our measurements re-
vealed that protein synthesis rates were highly similar across
yfp variants, with less than 1.4-fold variation within all codon
families (Fig. 1D, grey bars). Thus, under rich conditions, the
degeneracy of the genetic code remains intact with respect
to protein synthesis. Strikingly, under amino acid-limited
growth, codon families split into a hierarchy of YFP synthesis
rates (Fig. 1C, 1D). We found that some synonymous codons,
such as CTA for leucine, were highly sensitive to environmen-
tal perturbation, causing YFP synthesis rates to be near zero
in response to the limitation of these codons’ cognate amino
acids. Conversely, other synonymous codons, such as CTG
for leucine, were more robust to the same perturbation with
synthesis rates of YFP up to 100-fold higher than the sensitive
ones1. In addition to fluorescence, this difference in robust-
ness was reflected in protein levels measured with Western
blotting (Fig. S1). Notably, even a single substitution to a
perturbation-sensitive codon in the yfp coding sequence re-
sulted in more than a 2-fold difference in YFP synthesis rate
during limitation for the cognate amino acid, without any
effect on synthesis rate during amino acid-rich growth (Fig.
1We define codons as robust when the synthesis rate from the corresponding yfp variant during
cognate amino acid limitation is higher than the average synthesis rate within that codon family.
Similarly, we define codons as sensitive when the synthesis rate from the corresponding yfp variant
during cognate amino acid limitation is lower than the average synthesis rate within that codon
family.
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S2). Only those codons that were cognate to the limiting
amino acid caused splitting of YFP synthesis rates (Fig. S3).
Interestingly, the splitting was more acute for codon fami-
lies with six-fold degeneracy (Leu, Arg, Ser), while splitting
was weaker for codon families with four-, three- and two-fold
degeneracies (Fig. 1D, first row vs. second row). These re-
sults support the idea that greater degeneracy typically allows
systems to exhibit wider range of responses to environmental
perturbations [2]. In subsequent experiments, we focused on
the two codon families, leucine and arginine that displayed
the largest range of splitting. These two families constitute
16% of codons across the genome of E. coli.
Intracellular determinants of the hierarchy among synony-
mous codons.We sought to identify the intracellular parame-
ters that determine the observed hierarchy of degeneracy split-
ting during amino acid limitation. To this end, we quantified
the robustness of synthesis rate to amino acid limitation as
the ratio of YFP synthesis rates between amino acid-limited
and amino acid-rich growth phases. Protein synthesis rate is
known to be correlated with codon usage and tRNA abun-
dance during artificial over-expression of proteins [12, 13].
However, we found that robustness of YFP synthesis to amino
acid limitation was not correlated with either codon usage or
tRNA abundance (r2 = 0.08 and 0.00, squared Spearman
rank-correlation, Fig. S4). We then considered determinants
of protein synthesis that might be important specifically dur-
ing amino acid limitation. tRNA isoacceptors are uniformly
charged (aminoacylated) at about 80% under amino acid-rich
conditions [14, 15]. However during perturbations such as
amino acid limitation, some tRNA isoacceptors cognate to
the amino acid are almost fully charged while other isoaccep-
tors in the same family have charged fractions that are close
to zero [10, 16]. A theoretical model proposed that such se-
lective charging arises from differences in the relative supply
and demand for charged tRNA isoacceptors [9]. While it is
unclear how this mechanism could solely control protein lev-
els, charged tRNA play an essential role as substrates for the
elongation of ribosomes across individual codons [17]. Con-
sequently, we hypothesized that selective charging of tRNA
isoacceptors also underlies the observed splitting in synthesis
rates among yfp variants. Consistent with this hypothesis,
charged fractions of leucine and arginine tRNA isoacceptors
during limitation of cognate amino acid starvation measured
in a previous work [10] were correlated with the robustness of
synthesis rates from yfp variants after accounting for codon-
tRNA assignments (r2 = 0.78, Fig. S5).
We experimentally tested whether varying the concentra-
tion of charged tRNA could change the hierarchy of protein
synthesis rates initially revealed by amino acid limitation. To
this end, we co-expressed each one of the leucine or arginine
tRNA isoacceptors together with each of the six leucine or
arginine variants of yfp, respectively (Fig. 2). Previous work
[16] showed that overexpression of a single tRNA isoacceptor
cognate to a limiting amino acid enables it to compete better
in the common charging reaction against other isoacceptors.
As a result, charged tRNA concentration of the overexpressed
isoacceptor increases, while charged tRNA concentrations of
the remaining isoacceptors for that amino acid decrease or re-
main unchanged [16]. We found that yfp variants constructed
with perturbation-sensitive codons exhibited higher synthe-
sis rates upon co-expression of tRNA isoacceptors cognate to
those perturbation-sensitive codons (Fig. 2, A-B , bottom
three rows, solid black-outlined squares). Conversely, yfp vari-
ants with perturbation-robust codons exhibited lower protein
synthesis rates upon co-expression of non-cognate tRNA isoac-
ceptors (Fig. 2, A-B, top three rows, non-outlined squares).
These two patterns of changes in YFP synthesis rate mir-
ror previously measured changes in charged tRNA concentra-
tion upon tRNA co-expression [16], thereby suggesting that
the observed hierarchy in synthesis rates of yfp variants are
tightly coupled with the concentrations of cognate charged
tRNA isoacceptors during amino acid limitation. By con-
trast, tRNA co-expression did not affect synthesis rates from
yfp variants in the absence of perturbation, i.e., during amino
acid-rich growth (Fig. 2C). We observed several codon-tRNA
pairs with mismatches at the wobble position but that do
not satisfy known wobble-pairing rules (Table S9), and that
showed an increase in YFP synthesis rate upon co-expression
of the tRNA isoacceptor during amino acid limitation (Fig. 2,
A-B , dashed black-outlined squares).
A codon robustness index for endogenous proteins.We in-
vestigated whether the hierarchy of synthesis rates measured
for the synthetic yfp variants also governs the synthesis of
endogenous proteins of E. coli. We first devised a general pa-
rameter, hereafter called the codon robustness index (CRI),
to characterize the robustness of any protein’s synthesis rate
to an environmental perturbation associated with limitation
of a specific amino acid (Fig. 3A). We defined CRI as a prod-
uct of codon-specific weights wcodon, and we inferred these
weights from the synthesis robustness of yfp variants to limita-
tion for their cognate amino acid (Fig. 3B). Our formulation
of CRI is based on the simplifying assumption that each codon
decreases protein synthesis rate by a factor wcodon that is in-
dependent of the codon’s intragenic location, the presence of
other codons in the coding sequence, or the specific cellular
role of the encoded protein. By definition, wcodon is unity for
codons that are not cognate to the limiting amino acid, and
perturbation-robust codons have a higher wcodon value than
perturbation-sensitive codons for the limiting amino acid.
To test the predictive power of CRI, we selected 92 E.
coli open reading frames (ORFs) that span a broad range of
leucine CRI values and functional categories (Fig. S7, Table
S1). We expressed the corresponding proteins constitutively
as N-terminus fusions with YFP2 in an E. coli strain aux-
otrophic for leucine (Fig. 3C, Inset,). Upon leucine limita-
tion, we found a strong correlation between the robustness of
protein synthesis rates from the 92 ORF-yfp fusions and their
leucine CRI values (Fig. 3C, r2 = 0.61, P = 10−23, squared
Spearman rank-correlation). Similarly, arginine CRI was also
strongly correlated with robustness of a library of 56 ORF-yfp
fusions during arginine limitation (r2 = 0.59, P = 10−12, Fig.
S8, Table S2). By contrast, standard measures of transla-
tion efficiency under amino acid-rich conditions such as codon
adaptation index [18], tRNA adaptation index [19] or folding
energy of the mRNA around the start codon [20] displayed
only a weak correlation with protein synthesis rate from the
ORF-yfp fusions during amino acid-rich growth (r2 = 0.10,
0.08, and 0.02 resp., Fig. S9). We further found that changes
in Leu CRI calculated from the yfp data could predict both
the effect of tRNA co-expression and that of synonymous mu-
tations on protein synthesis from E. coli ORFs during leucine
limitation (Fig. 3D, Fig. S10). Importantly, similar to our
results using yfp reporters, neither tRNA co-expression nor
synonymous mutations for E.coli ORF-yfp fusions had a sig-
nificant effect on the synthesis rates from these ORFs during
leucine-rich growth in absence of environmental perturbations
2The YFP fusion partner in the 92 ORF-yfp fusions used for testing Leu CRI was encoded by the
CTG variant of yfp that has the highest, most robust synthesis rate during leucine limitation. Sim-
ilarly, the YFP fusion partner in the 56 ORF-yfp fusions used for testing Arg CRI was encoded by
the AGA variant of yfp that has the highest, most robust synthesis rate during arginine limitation.
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(Fig. S11). Thus the degeneracy of the genetic code under-
lies the levels of endogenous protein production only during
response to environmental perturbations.
Consequences of degeneracy lifting for fitness and gene reg-
ulation.Degeneracy splitting in physical systems can be ex-
ploited to encode information related to the environmental
context [21, 22]. We asked whether bacteria might similarly
exploit the degeneracy splitting of genetic code during re-
sponse to amino acid limitation. Hence we tested whether the
expression of amino acid biosynthesis genes that enable bacte-
ria to adapt to amino acid limitation is affected by the hierar-
chy between robust and sensitive codons. We found that mu-
tating codons that are perturbation-robust to those that are
perturbation-sensitive in the leucine-biosynthesis genes leuA,
leuC and leuD, and the arginine biosynthetic gene carA de-
creased their protein synthesis rate during cognate amino acid
limitation, but not during amino acid-rich growth (Fig. S12).
Interestingly, in the case of leuA and carA, the same synony-
mous mutations also resulted in a fitness cost for prototrophic
strains upon downshift from amino acid-rich to amino acid-
poor conditions (Fig. 4A). Thus synonymous mutations can
have a significant fitness cost during an environmental pertur-
bation, which is distinct from that measured under nutrient-
rich conditions in the absence of any perturbation [20, 23].
However swapping codons that are perturbation-robust to
those that are perturbation-sensitive in other biosynthesis
genes (see argA and leuC in Fig. 4A) did not significantly
affect fitness, suggesting that the hierarchy of robust and sen-
sitive codons might be selectively utilized by bacteria to reg-
ulate genes within a single metabolic pathway.
Perturbations associated with amino acid limitation in E.
coli can result in two distinct outcomes, depending on the en-
vironmental conditions: On one hand, when substrates used
in amino acid biosynthesis are still abundant in the environ-
ment, the cell up-regulates corresponding biosynthesis genes
to mitigate the limitation of amino acids and resume growth.
On the other hand, in the absence of substrates for amino acid
biosynthesis, E. coli can survive a prolonged period in amino
acid-poor environments through a cellular response mediated
by sigma factors [24, 25]. We found that genes encoding sev-
eral stress-response sigma factors (rpoS, rpoE and rpoH ) are
enriched in TTA and TTG, the leucine codons that ensure ro-
bust protein synthesis during leucine limitation (Fig. 4B, top
panel). By contrast, genes for the housekeeping sigma factor
(rpoD) and a few minor sigma factors (fecI, fliA) are enriched
for CTC and CTT, which are sensitive to leucine limitation.
This contrasting pattern is observed for leucine (but not for
arginine), and is further mirrored by the change in transcript
abundance for sigma factor genes in response to leucine lim-
itation (Fig. 4B, bottom panel). Hence degeneracy splitting
in the genetic code might be exploited in concert with tran-
scriptional control to regulate protein levels.
Discussion
In summary, we have found that the degeneracy of the genetic
code does not have a role in regulating protein synthesis dur-
ing amino acid-rich growth. By contrast, the splitting of this
degeneracy upon reduction in amino acid supply has a potent
effect on protein synthesis that results in up to 100-fold dif-
ferences in protein synthesis rates between synonymous gene
variants. Such a large role for synonymous codons in protein
synthesis is surprising given that other post-transcriptional
mechanisms such as protein degradation are known to play a
significant role upon amino acid limitation [26]. We identified
competition between tRNA isoacceptors for aminoacylation
as a key determinant of the hierarchy of protein synthesis
rates during amino acid limitation. Low concentration of a
charged tRNA isoacceptor can cause ribosomes to selectively
pause at its cognate codon3 and trigger ribosome jamming
[27], translation-recoding [28], mRNA cleavage [29, 30, 31] or
feedback-transcriptional control [32, 33]. It will be interesting
to find the relative contribution of these different molecular
processes to the degeneracy lifting uncovered here4. Here, we
have investigated the effect of a specific environmental pertur-
bation associated with amino acid limitation in the bacterium
E. coli. However, this type of perturbation plays a crucial
role in the lifecycle of other bacteria such as Myxococcus xan-
thus and Bacillus subtilis that undergo differentiation cued by
amino acid limitation [34, 35]. Protein synthesis during such
differentiation events might also be regulated by degeneracy
lifting of the genetic code. Moreover, degeneracy lifting could
be important during protein synthesis in eukaryotes, where
clinically-important conditions such as neoplastic transforma-
tion and drug treatment are often accompanied by a reduction
in amino acid supply [36, 37]. Therefore lifting the degener-
acy of the genetic code might emerge as a general strategy for
biological systems to expand their repertoire of responses to
environmental perturbations.
Materials and Methods
Summary of key methods are given below. Detailed methods for all exper-
iments and analyses are included in the Appendix.
Bacterial strains. All strains used in this study were obtained from
the E.coli Genetic Stock Center (CGSC), Yale University. Different aux-
otrophic strains were used depending on the amino acid that was limiting
in the growth medium (Table S5). Strains were stored as 20% glycerol
stocks at -80◦C either in 1ml cryo-vials or in 96-well plates (3799, Costar).
For experiments involving over 25 strains, a temporary 20% glycerol stock
was stored at -20◦C in 96-well PCR plates.
Plasmids. The pZ series of plasmids [49] were used for expression of
all genes constructed for this study. General features of the plasmid back-
bones are described here. Details on individual gene constructs that were
inserted into these plasmid backbones, including DNA sequences and plas-
mid maps, are in Appendix. A low-copy plasmid, pZS*11 [SC101* ori (3-4
copies/cell), AmpR (bla gene) and a constitutive PLtetO1 promoter] was
used for expression of all fluorescent reporter genes and their fusions. The
synthetic ribosome binding site (RBS) in the original pZS*11 backbone was
replaced by a modified T7-based RBS that resulted in efficient expression of
most coding sequences. A medium-copy plasmid, pZA32 [p15A ori (10-12
copies/cell), ChlR (cat gene) and PLlacO1 promoter] was used for expres-
sion of all tRNA genes. Strains with pZA32 plasmids were grown with
1mM IPTG to ensure constitutive expression of all tRNA genes. Standard
plasmids pUC18 and pUC19 were used as intermediate cloning vectors for
site-directed mutagenesis.
Gene synthesis and cloning. A single yfp sequence was built de novo
(synthesis by Genscript, USA). All subsequent yfp variants were constructed
using a site-directed mutagenesis kit (Stratagene). tRNA genes and E. coli
ORFs were amplified from the chromosome of a wild-type E. coli strain
(MG1655) by PCR (Details on cloning and genes sequences in Appendix).
Amino acid limitation experiments. Overnight cultures were inocu-
lated from glycerol stocks or fresh colonies and grown in a MOPS-based
rich-defined medium with 800µM of 19 amino acids and 10mM serine
at 30◦C with shaking. For experiments involving amino acid limitation,
overnight cultures were diluted 1:1000 into a similar rich-defined medium
3A recent genome-wide study found increased ribosome pausing at serine codons during serine-
limited growth of E. coli. Interestingly, ribosomes paused significantly only at four out of the six
serine codons, and these four codons are precisely the same ones that caused YFP synthesis rate to
be sensitive to serine limitation in our experiments (Fig. S13).
4We measured the change in mRNA levels of different yfp variants in response to amino acid
limitation. Changes in mRNA levels were correlated with corresponding changes in YFP synthesis
rates upon amino acid limitation (Fig. S14), but were smaller than expected.
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as the overnight cultures. However the amino acid, whose limitation was to
be induced, was added at a reduced concentration and supplemented with
its methyl-ester analog (see Table S6 for exact concentrations). Amino
acid methyl-esters are inefficiently metabolized analogs of the correspond-
ing amino acids and have been previously used for steady growth of E. coli
under amino acid limiting conditions [51, 52] (see Figs. S15 and S16 for
the effect of methyl-ester on growth and measured robustness during amino
acid limited growth). Slight variations in the initial concentration of either
the limiting amino acid or its methyl-ester only results in shifting of the
transition to a higher or lower cell density without appreciable changes in
growth rate (see Notes S1 and S2). Growth and fluorescence were quanti-
fied using a standard 96-well plate reader integrated with a robotic system.
Further details on growth protocols are given in Appendix.
Analysis of cell density and fluorescence time series. Matlab R2009
(Mathworks) was used for all analyses unless otherwise mentioned. All
correlations and P-values reported in this work were calculated using the
Matlab command ‘corr’ with the ‘Type’ option set to either ‘Spearman’
or ‘Pearson’ as appropriate. Growth and fluorescence time series were fit
with exponential and linear curves in the amino acid rich and amino acid
limited growth regimes, respectively, and the onset time of amino acid
limited growth was automatically inferred from their intersection. Protein
synthesis rate, S was calculated as:
Protein synthesis rate S =
1
Absorbance
×
d(Fluorescence)
d(time)
[1 ]
First, the above formula was evaluated at the onset time of amino acid
limited growth using the exponential fits for absorbance and fluorescence
data in the amino acid rich growth regime. Next, the same formula was
evaluated at the onset time using the linear fits for absorbance and fluo-
rescence data in the amino acid limited growth regime. These two values
correspond to the protein synthesis rates reported for the amino acid rich
and amino acid limited growth regimes (such as the data in Fig. 1D).
Further details of this analysis are given in Appendix.
Calculation of CRI. CRI for a protein coding sequence corresponding to a
limiting amino acid was calculated by multiplying the wi values for codons
cognate to the limiting amino acid in that sequence. wi values shown in
Fig. 3B were calculated using the robustness of protein synthesis of the
corresponding yfp variants during cognate amino acid limitation (Fig. 1D).
Based on our non-cognate limitation experiment (Fig. S2), the wi values
for all codons other than those cognate to the limiting amino acid are set
to be equal to 1. For illustration, we demonstrate the calculation of wi for
the six leucine codons below. The exact same procedure was followed for
other synonymous codon families. Taking log2 wi ≡Wi for each codon,
and log2 (robustness during amino acid limited growth) ≡ SR for each
yfp variant,
7×WCTA + 15×WCTG = SRyfp,CTA [2 ]
7×WCTC + 15×WCTG = SRyfp,CTC [3 ]
22×WCTG = SRyfp,CTG [4 ]
7×WCTT + 15×WCTG = SRyfp,CTT [5 ]
7×WTTA + 15×WCTG = SRyfp,TTA [6 ]
7×WTTG + 15×WCTG = SRyfp,TTG [7 ]
The multiplicative factors on the LHS in front of Wi correspond to the
frequency of the Leu codon i in the corresponding Leu variant of yfp (see
Fig. 1A). The RHS is the measured (log2) robustness of protein synthesis
from the corresponding yfp variant during Leu limitation (see Fig. 1D).
These equations were solved simultaneously to determine the wi value for
each Leu codon. Revised wi values based on yfp measurements in the
presence of GAGLeu2 tRNA (Fig. 2) were used for calculation of Leu CRI
in the case of GAGLeu2 tRNA co-expression with E. coli ORFs (Fig. 3D).
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Fig. 1: Degeneracy lifting associated with amino acid limitation.
(A) A library of 29 variants of the yellow fluorescent protein gene (yfp) was synthesized. In this library, each variant (represented
as a horizontal line) was designed to measure the effect of one specific codon on protein synthesis rate. The identity of this
codon and that of its cognate amino acid is indicated to the left of each yfp variant, and the locations of this codon along yfp
are represented as thick vertical bars. Other codons for the same amino acid that were identical across all yfp variants in each
codon family are represented as thin vertical bars.
(B) Each yfp variant was constitutively expressed from a low-copy vector (SC101* ori, 2 copies / chromosome) in E. coli
strains that were auxotrophic for one or more of seven amino acids.
(C) To induce amino acid limited growth, we adjusted the initial concentration of an amino acid in the growth medium to
a level below that is required for reaching saturating cell density. A methyl-ester analog of the amino acid supported steady
growth in the amino-acid limited phase. Growth and fluorescence curves for two yfp variants, CTA, red, and CTG, black, are
shown as illustrative examples of degeneracy splitting upon limitation for the cognate amino acid, leucine.
(D) YFP synthesis rates during limitation for cognate amino acid – blue; YFP synthesis rates during amino acid-rich growth
– grey. YFP synthesis rate was defined as the rate of fluorescence change divided by the cell density. Synthesis rates were
normalized by the maximum value within each synonymous codon family, and separately in the amino acid-rich and amino
acid-limited growth phases. Normalization factors (amino acid – rich, limited): Leu – 94, 81; Arg – 89, 113; Ser – 217, 343;
Pro – 306, 49; Ile – 295, 45; Gln – 185, 83; Phe – 311, 20; (arbitrary units). Error bars show standard error over three replicate
cultures.
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Fig. 2: Altering the hierarchy of degeneracy splitting among synonymous codons.
The five leucine (arginine) tRNA isoacceptors were co-expressed together with each of the six leucine (arginine) yfp variants
resulting in thirty tRNA-yfp combinations for leucine (arginine).
(A, B) Each square in the left (right) table corresponds to the difference in YFP synthesis rates of each yfp variant between
the tRNA co-expressed strain and the parent strain without extra tRNA during leucine (arginine) limitation. YFP synthesis
rates were defined in the same manner and normalized by the same factor as in Fig.1D. YFP synthesis rate of the parent strain
without extra tRNA during amino acid limitation is shown on the left of each table (same data as in Fig. 1D). tRNA isoacceptor
names are preceded by their unmodified anticodon sequences. Solid black-outlined squares correspond to codon–tRNA pairs
that satisfy wobble-pairing rules after accounting for known post-transcriptional tRNA modifications (Table S9). Dashed black-
outlined squares correspond to codon–tRNA pairs that do not satisfy known wobble-pairing rules but that show a significant
increase in YFP synthesis rate upon co-expression of the tRNA isoacceptor. UCGArg2m is a non-native arginine tRNA that
was created by mutating the anticodon sequence of the ACGArg2 gene. Standard error was less than 0.05 for all squares.
(C) Histogram of differences in YFP synthesis rate of yfp variants upon tRNA co-expression. Amino acid limited growth: 42%
median difference; Amino acid-rich growth: 9% median difference (n = 60, aggregated for leucine and arginine). Change in
YFP synthesis rate between each tRNA co-expressed strain and its parent strain expressing no extra tRNA was calculated as
a percentage of the largest value between the two YFP synthesis rates.
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Fig. 3: Degeneracy lifting for endogenous proteins.
(A) The effect of each codon on the synthesis rate, S, of a protein during amino acid limitation was modeled by a codon-specific
weight, wcodon. The codon robustness index (CRI) for any protein coding sequence was defined as the product of wcodon values
for all codons in that sequence that are cognate to the limiting amino acid.
(B) wcodon values for leucine and arginine codons during limitation for their cognate amino acids were estimated from protein
synthesis rates of the corresponding yfp variants (Methods). wcodon values for all codons not cognate to the limiting acid were
set to 1.
(C) Ninety-two open reading frames (ORFs) from the E. coli genome were cloned as N-terminal fusions to YFP downstream
a constitutive promoter into a low-copy vector (Inset, Methods). Robustness to leucine limitation is quantified as the ratio
of protein synthesis rates between leucine-limited and leucine-rich growth phases. This measured robustness was correlated
with estimated Leu CRI values for the 92 ORF-yfp fusions (r2 = 0.61, squared Spearman rank-correlation, P = 10−20). 11
ORFs had measured robustness below the lower limit of the vertical axis (Table S1), but were included in the calculation of
r2. Protein synthesis rates were normalized by the synthesis rate for the CTG variant of yfp. Error bars show standard error
over three replicate cultures.
(D) Two sets of ORF-yfp fusions (21 total ORFs) were co-expressed with GAGLeu2 tRNA. Based on the yfp data (Fig. 2A), we
estimated a higher CRI for the first set (11 ORFs) and a lower CRI for the second set (10 ORFs) upon GAGLeu2 co-expression
(Left panel, Methods). Hence we predicted that the first set should show an increase in robustness of protein synthesis during
leucine limitation while the second set should show a decrease. These predictions agreed with measured changes for 20 of the
21 ORFs (Right panel, r2 = 0.57, P = 10−4). Error bars show standard error over three replicate cultures. Several error bars
are smaller than data markers.
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Fig. 4: Fitness cost and transcriptional control reflect degeneracy lifting.
(A) Four different prototrophic E. coli strains were created. Each of these strains had one of the four amino acid biosynthesis
genes argA (Arg), carA (Arg), leuA (Leu) and leuC (Leu) replaced at the native locus by a corresponding synonymous mutant
ORF. These mutants were designed such that three to five perturbation-robust codons in wild-type ORF were replaced by
perturbation-sensitive codons in the mutant ORF (see Fig. S12, B). The strains were grown in medium supplemented with
all 20 amino acids at 800µM , and then diluted into a medium lacking either leucine (left panel) or arginine (right panel).
Growth lag was calculated as the time taken by each strain to reach OD600 of 0.3 relative to a reference culture of the same
strain grown in 800µM of all 20 amino acids. Difference in growth lag between the leuA mutant and the two controls during
leucine downshift (left panel) was 9.2 ± 2.8 min, P = 10−3. Difference in growth lag between the carA mutant and the two
controls during arginine downshift ( right panel) was 7.8 ± 1.2 min, P = 10−6. Standard errors were calculated over six
biological replicates for each mutant. P -values were calculated using two-tailed t-test between the leuA or carA mutant and
the corresponding controls.
(B) (Top panel) Genes encoding sigma factors and leucine biosynthesis genes in E. coli are biased in their Leu CRI values,
as quantified using a z -score that measures the normalized deviation from the expected CRI value based on genome-wide
codon frequencies (Appendix). The most frequent leucine codon CTG was excluded in this analysis since its frequency varies
significantly with expression level under nutrient-rich conditions [41]. (Bottom panel) Fold-change in mRNA abundance in
response to leucine limitation for sigma factor genes and leucine biosynthesis operons was measured using RT-qPCR. Fold-
change of the gapA gene was used for internal normalization. Error bars show standard error over triplicate qPCRmeasurements.
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Appendix
Bacterial strains
All strains used in this study were obtained from the E.coli
Genetic Stock Center (CGSC), Yale University. For amino
acid limitation experiments, standard auxotrophic strains
(Table S5) were used depending on the amino acid that was
limiting in the growth medium, unless mentioned otherwise.
Strain CP78 was used for experiments involving leucine and
arginine limitation. This strain has been used extensively in
previous amino acid limitation studies [42, 43, 44, 45, 15, 10]
and its multiple auxotrophy makes it a convenient choice for
experiments involving limitation for several amino acids. The
auxotrophic strains corresponding to the remaining amino
acids are from the Keio-knockout collection [46], and are
the commonly used auxotrophic strains for that amino acid
(http://cgsc.biology.yale.edu/Auxotrophs.php).
For the growth lag measurements in Fig. 4A, the pro-
totrophic strain MG1655 (Table S5) was used as the wild-type
background. This background strain was tagged with yfp or
rfp at the attBλ locus (this tagging was a remnant from ear-
lier experiments not related to this work, and has no relevance
to any results presented here). Site-directed mutagenesis was
used to create the synonymous mutant coding sequences for
leuA, leuC, leuD, carA, argA and argF using the protocol de-
scribed in the section on gene synthesis and cloning. Then
to insert these mutant ORFs into their native locus without
any additional markers, a two-step strategy based on λ Red-
mediated homologous recombination [47] was used: In the
first step, the respective wild-type ORF was replaced by a kan
resistance gene, and in the second step the kan gene was re-
placed by the mutant ORF without any additional markers by
selecting on M9-glucose plates for prototrophy of the respec-
tive amino acid. Plasmid pSIM5 [48] was used as the helper
plasmid and a previously published recombineering protocol
[48] was used without any modifications.
For RT-qPCR (Fig. 4B), a leucine auxotroph of MG1655
was created by deleting the leuB gene using the λ Red-
mediated homologous recombination protocol outlined above.
For Western blots (Fig. S1), the auxotrophic strains in Ta-
ble S5 were further modified by insertion of the tet repressor
gene at the attBλ site using a previous method based on λ
integrase-mediated site-specific recombination [49]. The pres-
ence of Tet repressor enabled inducible control of YFP expres-
sion. The Western blots for leucine and arginine yfp variants
were performed in an MG1655 auxotroph strain background
instead of the CP78 strain. The CP78 strain has lower trans-
formation efficiency which prevented integration of the tet re-
pressor gene into the chromosome. Strains were stored as 20%
glycerol stocks at -80◦C either in 1ml cryo-vials or in 96-well
plates (3799, Costar). In addition, for experiments involving
over 25 strains, a temporary 20% glycerol stock was stored at
-20◦C in 96-well PCR plates.
Plasmids
The pZ series of plasmids [49] were used for extra-
chromosomal expression of genes. General features of the plas-
mid backbones are described here. Specific gene constructs
that were cloned into these backbones is described in the
section on gene synthesis and cloning. A low-copy plasmid,
pZS*11 [SC101* ori (3-4 copies/cell), AmpR (bla gene) and
a constitutive PLtetO1 promoter] was used for expression of
all fluorescent reporter genes and their fusions. The synthetic
ribosome binding site (RBS) in the original pZS*11 backbone
was replaced by a modified T7 -based RBS that resulted in
efficient protein expression from most coding sequences. A
medium-copy plasmid, pZA32 [p15A ori (10-12 copies/cell),
ChlR (cat gene) and PLlacO1 promoter] was used for expres-
sion of all tRNA genes. Strains with pZA32 plasmids were
grown with 1mM IPTG to ensure constitutive expression of
all tRNA genes. Standard plasmids pUC18 and pUC19 (In-
vitrogen) were used as intermediate cloning vectors for site-
directed mutagenesis. Plasmid pSIM5 (13) was used as the
helper plasmid expressing the λ-Red system for all chromo-
somal modifications in this project (except for Tet repressor
insertion mentioned in the previous section).
Growth and fluorescence measurements
Overnight cultures were inoculated either from freshly grown
single colonies or, in experiments involving more than 25
strains, from temporary glycerol stocks stored at -20C.
Overnight cultures were grown in a modified MOPS rich-
defined medium [50] made with the following recipe: 10X
MOPS rich buffer, 10X ACGU nucleobase stock and 100X
0.132M K2HPO4 (Teknova, Cat. No. M2105) were used
at 1X final concentration as in the original recipe. In ad-
dition, the overnight growth medium contained 0.5% glucose
as carbon source, 10−4% thiamine and 800µM of 19 amino
acids and 10mM of serine. pH was adjusted to 7.4 using 1M
NaOH and appropriate selective antibiotics (50µg/ml ampi-
cillin and/or 20µg/ml chloramphenicol) were added. Amino
acids, glucose, thiamine and antibiotics were purchased from
Sigma. 1ml overnight cultures were grown in 2ml deep 96-well
plates (40002-014, VWR) at 30◦C with shaking at 1350rpm
(Titramax 100 shaker) for 12 to 16 hours.
For amino acid limitation experiments, overnight cultures
were diluted 1:1000 into 1ml of the same MOPS rich-defined
medium as the overnight cultures. However the amino acid
whose limitation was to be induced was added at a reduced
concentration and supplemented with its methyl ester ana-
log (Table S6). Amino acid methyl esters are analogs of the
corresponding amino acids and have been previously used for
steady growth of E. coli under amino acid limiting conditions
[51, 52] (see Figs. S15 and S16 for the effect of methyl ester
on growth and robustness of YFP synthesis). Addition of the
methyl esters results in a steady but limiting supply of the
amino acid due to slow hydrolysis of the ester (see Note 1).
Concentrations of the amino acid and its methyl ester were
chosen such that the cultures consumed the limiting amino
acid and entered amino acid-limited growth at an OD600 of
0.6-0.7 (corresponding to an OD600 value of 0.2-0.25 in our
96-well plate reader). Slight variations in the initial concen-
tration of either the limiting amino acid or its methyl ester
shift the transition to a higher or lower cell density without
appreciable changes in growth rate (see Note 2). Except for
a single limiting amino acid, the remaining 19 amino acids
were present at the overnight culture concentrations during
the amino acid limitation experiments. For proline limita-
tion, no proline was necessary in the growth medium since
proline methyl ester supported growth at the same rate as
proline until the OD600 reached around 0.6.
Diluted overnight cultures were grown in 2ml deep 96-well
plates for 3 hours at 30◦C with shaking at 1350rpm (Titra-
max 100 shaker). After this time interval, 3 aliquots of 150µl
from each culture was pipetted into 3 wells of 3 different
96-well plates (3799, Costar). Wallac Victor2 plate reader
(PerkinElmer) was used to monitor cell density (absorbance
at 600nm) and YFP synthesis (fluorescence, excitation 504nm
and emission 540nm). Each plate was read every 15 min using
a robotic system (Caliper Life Sciences) and shaken in between
readings (Variomag Teleshake shaker) for a total period of 6-
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10 hours. Temperature of 30◦C and relative humidity of 60%
was maintained throughout the experiment.
In the case of experiments without methyl ester (Figs.
S15 and S16), the same protocol mentioned above was fol-
lowed but the methyl esters were not added to the growth
medium. For the RT-qPCR measurements shown in Fig. 4B,
overnights cultures were diluted 1:1000 into the same medium.
Then when the OD600 reached 0.5, the cells were spun down
at 3000g for 5 min and then re-suspended in the same medium
but either with or without leucine. Total RNA was extracted
(see protocol below) after 30 min of shaking at 30◦C, 200rpm.
For the growth lag measurements shown in Fig. 4A,
overnight cultures of prototrophic strains were diluted 1:200
into medium either with or without one of leucine and argi-
nine. Growth lag was measured as the difference in time taken
to reach OD600 of 0.3 between two cultures of the same strain
– one growing in the presence of either leucine or arginine and
another growing in its absence.
Gene synthesis and cloning
All gene sequences constructed for this study are provided
in the gene sequences.fasta file. Plasmid backbone sequences
are provided in the plasmid sequences.genbank file. Primer
sequences used for cloning will be provided upon request. For
all primers, 18 to 22bp homologies without any special primer
design criteria were sufficient for successful PCR amplification
with Phusion High-Fidelity DNA polymerase (NEB).
Initial yfp construct.All yfp variants used in this study were
modified starting from a single yellow fluorescent protein gene
sequence (called yfp0 in the sequence file and plasmid map).
This yfp0 sequence encoded the fast-maturing ‘Venus’ vari-
ant of YFP [53]. All 238 codons of yfp0 were chosen such
that they were decoded by abundant tRNA isoacceptors for
each amino acid. Such a choice of codons ensured that the
native level of demand for each tRNA isoacceptor inside the
cell was minimally perturbed by the low-copy expression of
fluorescent reporter genes. The yfp0 sequence was built de
novo (synthesis by Genscript, USA). The synthesized yfp0 se-
quence was cloned between the KpnI and HindIII restriction
sites of the pZS*11 plasmid vector using standard molecular-
biology techniques (19). The plasmid map of the resulting
construct, pZS*11-yfp0 is shown in Fig. S17.
Synonymous variants of yfp .A subset of codons in yfp0 cor-
responding to 7 amino acids (Leu, Arg, Ser, Pro, Ile, Gln, Phe)
were mutated to create the initial 29 synonymous variants of
yfp (yfp1 – yfp29 in the gene sequences.fasta file, sequences
in the same order as shown in Fig. 1A). The 4 yfp variants
corresponding to Pro (yfp19 -yfp22 ) had all the Pro codons
mutated to the most frequent CCG codon since the original
yfp0 sequence had a few CCA and CCT codons that are more
sensitive to Pro limitation. Similarly, all the Phe codons in
yfp0 were mutated to the most abundant Phe codon TTT
for the two Phe variants of yfp0 (yfp28 -yfp29 ). Both these
groups of variants (6 total) had higher overall fluorescence dur-
ing amino-acid rich conditions than the rest of the 23 variants.
This higher fluorescence is likely due to changes in secondary
structure near the ribosome binding region on the mRNA as
a consequence of mutations near ATG. However, this change
is common across all variants within the Pro and Phe syn-
onymous codon groups and hence is not responsible for the
differential response to cognate amino acid limitation mea-
sured within these synonymous codon groups.
For constructing the 29 yfp variants, yfp0 from pZS*11-
yfp0 was first cloned into a pUC19 cloning vector between the
KpnI and HindIII restriction sites. A commercial site-directed
mutagenesis kit (Quickchange Lightening Multi, Applied
Biosystems) was used to introduce the mutations correspond-
ing to each of the 29 variants and the manufacturer’s protocol
was followed. The resulting variants were verified by Sanger
sequencing and then cloned into the pZS*11 expression vector
backbone between the KpnI and HindIII sites. The 22 single
CTA variants of yfp (Fig. S2) were constructed using the same
procedure as above. The 29 yfp variants for Western blotting
(Fig. S1) were created using the same procedure as above, but
with the addition of a 22 codon sequence at the 5′ end that
encoded a 3X-FLAG peptide recognized by a commercially
available, anti-FLAG, antibody (Sigma). The 22-codon se-
quence is: GACTACAAAGACCATGACGGTGATTATAAA-
GATCATGACATCGACTACAAGGATGACGATGACAAG.
tRNA expression vectors.The 5 distinct Leu tRNA isoaccep-
tors encoded by the genes leuQ, leuU, leuW, leuX and leuZ,
and the 4 distinct Arg tRNA isoacceptors encoded by the
genes argV, argX, argU and argW were cloned between the
EcoRI and HindIII sites of the pZA32 expression vector (Fig.
S18). These genes were amplified by PCR from the chromo-
some of E. coli strain MG1655. In addition to these native
tRNA genes, a synthetic tRNA gene arg2m cognate to the
CGA Arg codon was also created. Normally, the ACGArg2
tRNA with ICG anti-codon reads the CGA codon inefficiently
through a purine-purine wobble pairing. Expressing a syn-
thetic tRNA with an anticodon UCG restores efficient read-
ing of this codon and is equivalent to increasing the supply
of the corresponding cognate tRNA isoacceptor. This syn-
thetic tRNA isoacceptor was created from the pZA32-argV
expression vector using overlap PCR to introduce the neces-
sary single bp mutation in the anticodon of argV. The pZA32
vectors with the tRNA genes were electroporated into strains
already containing the YFP expression vectors.
Library ofE. coli ORF-yfp fusions. 92 E. coli Open Read-
ing Frames (ORFs) were selected for experimental validation
of the Leu Codon Robustness Index (Leu CRI). These ORFs
were chosen to span a wide range of predicted Leu CRI values
and functional categories (Fig. S7 and Table S1). First, a
modified pZS*11-yfp0 vector backbone was created in which
the start codon of yfp0 was replaced by a GGSGGS hexa-
peptide linker sequence: GGTGGATCCGGCGGTTCT con-
taining a BamHI restriction site. Next, the 92 ORFs (without
the stop codon) were amplified by PCR from the chromo-
some of E. coli strain MG1655 with 5′-KpnI and 3′-BamHI
restriction site overhangs. These PCR fragments were cloned
into the modified pZS*11-yfp0 vector backbone containing the
BamHI restriction site. 13 of the 92 ORFs had either an in-
ternal KpnI or an internal BamHI site. In these cases, a larger
fragment that included adjoining sections of the pZS*11-yfp0
vector was constructed by overlap PCR and then cloned us-
ing other restriction sites (EcoRI or HindIII). Thus the final
constructs had one of the 92 E. coli ORFs connected through
a hexapeptide linker with yfp0. All the cloned sequences were
verified by PCR for inserts of right length and around 40 ORF
constructs were verified by Sanger sequencing. Two biologi-
cal replicates of each ORF construct were compared for their
synthesis robustness values as measured during the amino acid
limitation assay and these values showed a high degree of cor-
relation (Pearson ρ = 0.93, Fig. S19).
For validating the Arg codon robustness index (Arg CRI),
56 E. coli ORFs that included a subset of the above 92 ORFs
were chosen (Table S2). The cloning procedure was exactly
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analogous to the above 92 ORFs but with one difference: the
yfp0 part of the fusion construct was replaced by a synony-
mous variant of yfp0 (yfp7 ) that had the Arg codon AGA in-
stead of the CGT and CGC codons in the yfp0 sequence. The
codon AGA has the highest wi value among the Arg codons
(see Fig. 3B) and hence has a minimal effect on the measured
robustness of the ORF fusions during Arg limitation.
Co-expression of GAGLeu2-tRNA with E. coli ORF-yfp
fusions.Out of the 92 E. coli ORF-yfp fusions, 21 were cho-
sen for co-expression with the GAGLeu2 tRNA that is cog-
nate to the codons CTC and CTT. The 21 ORFs were chosen
such that 11 of them had a lower Leu CRI prediction than
their wild-type counterparts while the other 10 ORFs had a
higher Leu CRI prediction than their wild-type counterparts
(Table S3). This choice also corresponded respectively to ei-
ther high frequency of the non-cognate TTA and TTG codons
for GAGLeu2 or high frequency of the cognate codons CTC
and CTT. The strains containing the 21 ORF fusions were
each made electro-competent and then transformed with the
pZA32-leuU plasmid that expresses GAGLeu2.
Synonymous variants of E. coli ORF-yfp fusions.Out of
the 92 E. coli ORF-yfp fusions, 13 were selected for creating
synonymous mutants (Table S2). These 13 ORFs had a high
frequency of one or both of the Leu codons, TTA or TTG and
these codons were mutated to the Leu codon, CTC. All these
3 codons, TTA, TTG and CTC occur at similar frequencies
on average across the genome of E. coli.The 13 ORF-yfp fu-
sions were amplified by PCR from the pZS*11 vectors between
the EcoRI and XbaI restriction sites (see Fig. S17). These
fragments were cloned between EcoRI and XbaI sites of the
pUC19 cloning vector. A commercial site-directed mutagen-
esis kit (Quickchange Lightening Multi, Applied Biosystems)
was used to introduce the TTA, TTG → CTC mutations.
A unique primer was designed for each of the TTG or TTA
codons in the 13 ORFs, and these primers encoded the CTC
mutation. All the primers corresponding to each ORF were
mixed and then used in the mutagenesis reaction. This pro-
cedure resulted in mutant coding sequences with TTA, TTG
→ CTC mutations at random locations. 10 colonies for each
ORF were sequenced and each unique mutant sequence was
then cloned into the pZS*11 expression vector. At the end of
the procedure, a total of 63 constructs were created that each
had between one and seven TTA, TTG → CTC mutations
(see gene sequences.fasta file for exact sequences).
Total RNA extraction
Total RNA was extracted for two different experiments (Figs.
4B, S14). Phenol-chloroform extraction method was used to
obtain total RNA. Briefly, 3ml of cells were quickly mixed
with 5ml of ice-cold water and harvested by centrifugation at
3000g for 10min. Cell pellets were re-suspended in 500µl of
0.3M sodium acetate-10mM EDTA, pH 4.8 buffer. The re-
suspended cells were mixed with 500µl of acetate-saturated
phenol-chloroform at pH 4.8, 50µl of 20% SDS and 500µl of
acid-washed glass beads (G1277, Sigma). The mixture was
shaken in a vortexer for 20 min at 4C. The aqueous layer
was extracted twice with acetate-saturated phenol-chloroform
at pH 4.8 and once with chloroform. Total RNA was pre-
cipitated with an equal volume of isopropanol and washed
with 70% ethanol-50mM sodium acetate pH 4.8 and finally
re-suspended in 200µl of RNase-free water. 20µl of the to-
tal RNA was treated with DNase (EN0521, Fermentas) to
remove residual DNA contamination (manufacturer’s instruc-
tions were followed). The DNA-free RNA was re-suspended
in 200µl of RNase-free water. Intact RNA was confirmed by
observation of sharp rRNA bands in native agarose gel elec-
trophoresis.
RT-qPCR
Reverse transcription (RT) was performed using 4µl of the
DNA-free RNA (100-200ng) and Maxima reverse transcrip-
tion kit (K1641, Fermentas), used according to the manufac-
turer’s instructions. Random hexamer primers were used for
priming the RT reaction. At the end of the RT reaction,
the 20µl reaction was diluted 100-fold and 10µl of this di-
luted sample was used for qPCR in the next step. qPCR was
performed using Maxima SYBR-Green qPCR kit (K0221, Fer-
mentas) and manufacturer’s instructions were followed. qPCR
was performed in triplicates for each RT reaction and appro-
priate negative RT controls were used to confirm the absence
of DNA contamination. gapA mRNA was used as internal ref-
erence to normalize all other mRNA levels. Standard curves
with 6 serial dilutions were used to optimize reaction condi-
tions and ensure amplification efficiency of between 90-100%
for the yfp and gapA amplicons. ∆∆Ct method was used to
obtain the change in mRNA levels due to amino acid limita-
tion. The qPCR primer sequences are given in Table S8.
Western blotting
Fresh colonies were used to inoculate overnight cultures.
These overnight cultures were then diluted 1:100 into 1ml
of rich-defined medium with all 20 amino acids (see section
on growth and fluorescence measurements for media composi-
tion). After approximately 3.5 hours of growth at 30◦C when
OD600 was ∼0.4, cells were spun down at 9000g for 1 min,
and then re-suspended in 1ml of rich-defined medium with-
out the amino acid whose limitation was to be induced. This
re-suspended culture was then split into two equal aliquots.
The limiting amino acid was added to one aliquot (as a rich-
medium control) while the other aliquot did not have the
limiting amino acid. The re-suspended medium also con-
tained 200ng/ml of anhydro-tetracycline in order to induce
the pLtetO1 promoter that controls the 3XFLAG-yfp vari-
ants. After growth at 30◦C for 60 min, cells were spun down
at 12000g, 1 min and re-suspended in 40-400µl of CellLytic B
buffer (Sigma, B7435). The buffer volume used was propor-
tional to the OD600 measured at the time of harvesting the
culture. The lysate was stored at -80◦C. 10µl of the lysate
was mixed with 2X Laemmli Buffer (Biorad) and then loaded
onto each lane of a pre-cast polyacrylamide gel (Biorad) and
SDS-PAGE was carried out at 100V for 120 min. Proteins
were transferred to a nitrocellulose membrane by semi-dry
blotting at 180mA for 60 min. The membrane was blocked
in 2% skim-milk-TBST overnight, and then incubated with
a 1:2000 dilution of an anti-FLAG antibody (F3165, Sigma)
in 10ml of 2% skim-milk-TBST with shaking at room tem-
perature for 90 min. After washing 4 times for 5 min with
TBST, the membrane was incubated with 1:2000 dilution of a
secondary HRP-conjugated antibody (7076, Cell Signaling) in
15ml of 2% skim-milk-TBST with shaking at room tempera-
ture for 60 min. After washing 4 times for 5 min with TBST,
the membrane was treated with an HRP substrate (L00354,
Genscript) for 5 min and exposed for 30s to a luminescence
imager.
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Analyses
Matlab R2009b (Mathworks) was used for all analyses unless
otherwise mentioned. All correlations and P-values reported
in this work were calculated using the Matlab command ‘corr’
with the ‘Type’ option set to either ‘Spearman’ or ‘Pearson’
as appropriate.
Growth and fluorescence analysis.Background absorbance
and fluorescence values (obtained from wells containing only
growth media) were subtracted from the measured time series
for each well. An exponential curve was fitted to the amino
acid-rich growth regime for all data points located at least
50 min before the onset of amino acid limitation. A straight
line was fitted to the amino acid-limited growth regime for all
data points located at least 50 min after the onset time. These
fits were performed using the Matlab command ‘fit’, and the
in-built library options ‘Exp1’ and ‘Poly1’ respectively. To
automatically identify the onset time, the intersection point
between the two fitted curves was designated as the onset time
of amino acid limitation. This inferred onset time coincided
with the onset time identified through visual inspection of the
growth curves.
To minimize noise in calculated protein synthesis rates, an
exponential curve was fitted to the amino acid-rich regime of
the fluorescence time-series and a straight line was fitted to
the amino acid-limited regime of the fluorescence time-series.
These fits were performed using the Matlab command fit, and
the in-built library options ‘Exp1’ and ‘Poly1’ respectively.
Protein synthesis rate, S was calculated as
Protein synthesis rate S =
1
Absorbance
×
d(Fluorescence)
d(time)
[8]
First, the above formula was evaluated at the onset time of
amino acid limitation using the exponential fits for absorbance
and fluorescence data in the amino acid rich growth regime.
Next, the same formula was evaluated at the onset time us-
ing the linear fits for absorbance and fluorescence data in the
amino acid limited growth regime. These two values corre-
spond to the protein synthesis rates reported for the amino
acid rich and amino acid limited growth regimes (such as the
data in Fig. 1D). The protein synthesis rates were normalized
within each synonymous codon family and for each growth
condition. Robustness of protein synthesis to amino acid lim-
itation was calculated as the ratio of normalized protein syn-
thesis rates between the amino acid rich and amino acid lim-
ited growth regimes.
In the case of the experiment without methyl ester (Fig.
S15 and Fig. S16), the onset time of amino acid limited growth
was determined exactly as above. Then starvation robustness
was calculated as the normalized ratio of total fluorescence
increase after the onset of amino acid limited growth to the
fluorescence increase before this onset. Total fluorescence in-
crease rather than protein synthesis rate was used for this
analysis since protein synthesis rates decreased continuously
to zero after the onset of amino acid limited growth in the
absence of methyl ester analogs.
Calculation of CRI.CRI for a protein coding sequence corre-
sponding to a limiting amino acid was calculated by multiply-
ing the wi values for codons cognate to the limiting amino
acid in that sequence. wi values in Fig. 3B were calcu-
lated using the robustness of protein synthesis of the cor-
responding yfp variants during cognate amino acid limita-
tion (Fig. 1D). Based on the non-cognate amino acid lim-
itation experiment (Fig. S2), the wi values for all codons
other than those cognate to the limiting amino acid are
set to be equal to 1. For illustration, we demonstrate
the calculation of wi for the six Leu codons below. The
exact same procedure was followed for other synonymous
codon families. Taking log2wi ≡ Wi for each codon, and
log2(robustness during amino acid limited growth) ≡ SR for
each yfp variant,
7×WCTA + 15×WCTG = SRyfp,CTA [9]
7×WCTC + 15×WCTG = SRyfp,CTC [10]
22×WCTG = SRyfp,CTG [11]
7×WCTT + 15×WCTG = SRyfp,CTT [12]
7×WTTA + 15×WCTG = SRyfp,TTA [13]
7×WTTG + 15×WCTG = SRyfp,TTG [14]
The multiplicative factors on the LHS in front of Wi corre-
spond to the frequency of the Leu codon i in the corresponding
Leu variant of yfp (see Fig. 1A). The RHS is the measured
(log2) robustness of protein synthesis from the corresponding
yfp variant during Leu limitation (see Fig. 1D). These equa-
tions were solved simultaneously to determine the wi value
for each Leu codon. Revised wi values (Table S7) based on
yfp measurements in the presence of GAGLeu2 tRNA (Fig. 2)
were used for calculation of Leu CRI in the case of GAGLeu2
tRNA co-expression with E. coli ORFs (Fig. 3D).
Leu and Arg CRI for E. coli ORFs. 4300 E. coli ORF se-
quences were parsed out from the MG1655 genome sequence
(NCBI website, Accession number: NC 000913, downloaded
on 14th Apr 2011). For each of these 4300 E. coli ORFs,
Leu or Arg CRI was calculated by multiplying the wi values
for either all Leu or all Arg codons respectively in the ORF
sequence. For the 63 synonymous variants of 13 ORFs (Fig.
S10), Leu CRI values were calculated using the same proce-
dure as above after accounting for the synonymous mutations.
For the 21 ORFs co-expressed with Leu2 tRNA (Fig. 3D), re-
vised wi values were first calculated using the method outlined
in the previous section (Table S7), and using measurements on
the 6 Leu variants of yfp complemented with GAGLeu2 tRNA
(3rd column in Fig. 2A). These revised wi values were then
used to calculate Leu CRI under tRNA co-expression for the
21 tRNA co-expressed ORFs applying the same procedure as
for the non co-expressed case.
Z-score for CRI.To quantify the deviation in CRI from its ex-
pected value for each of the 4300 ORFs in the E. coli genome,
1000 random coding sequences were generated for each ORF.
Each random version preserved the original amino acid se-
quence, but the codons for a single amino acid were sampled
randomly from a multinomial distribution based on the aver-
age frequency of codons for that amino acid in the genome.
CRI values were calculated for each random version of the
gene, and a distribution of CRI values was generated from
the 1000 random trials. The average, µCRI and standard de-
viation, σCRI of this CRI distribution was used to calculate
the Z-score for CRI as follows:
ZCRI =
CRIobserved − µCRI
σCRI
[15]
In the case of the Z-score for leucine shown in Fig. 4B, the
leucine codon CTG was not randomized in the above calcu-
lation and only the remaining 5 leucine codons: CTA, CTC,
CTT, TTA, and TTG were randomized. This step is impor-
tant since CTG, which is read by an abundant tRNA isoaccep-
tor, is enriched in highly-expressed genes, and such genes will
show up falsely as perturbation-robust genes because CTG is
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also the codon that is most robust to leucine limitation in our
experiments (see Fig. 1D).
Codon-specific bioinformatic measures.Codon usage in Fig.
S4 was calculated as the average frequency of each codon
across the genome of E. coli MG1655 (4300 ORFs). tRNA
concentrations in Fig. S4 were taken from previous work (see
Table 2 in [54]). Concentrations of all cognate tRNAs for each
codon were summed together. The codon-tRNA adaptation
index in Fig. S4 is taken from literature (see Table S2 in [55]).
The tAI value for the CGA codon was revised from the unreal-
istically low value of 0.00005 to 0.1333 as explained previously
[56]. For inferring codon elongation rates from charged tRNA
fractions (Fig. S5), we used the formula for codon elongation
rate from [9]:
1
vk
= τ0 +
1
Σitiαikik
, [16]
where vk is the elongation rate of codon k, τ0 is the codon-
independent elongation time across any codon, ti is the con-
centration of tRNA isoacceptor i that is cognate to codon
k, kik is the second-order rate constant for binding of the
ternary complex containing the charged isoacceptor i to the
ribosome at codon k, and αi is the charged fraction of isoac-
ceptor i. We calculated the codon elongation rates during
amino acid limitation using the measured charged fractions
from [10]. For amino acid rich conditions, we set the charged
fraction to be equal to unity. We used τ0 = 0.05s
−1 , and
kik = 2× 10
7M−1s−1 similar to [9]. The ratio of codon elon-
gation rates was then normalized within each codon family by
the maximum value within that family.
ORF-specific bioinformatic measures.Codon Adaptation In-
dex was calculated for each E. coli ORF using the method
in [18]. This calculation was implemented using the Codon-
AdaptationIndex class in the CodonUsage module of BioPy-
thon (version 1.58). tRNA Adaptation Index was calcu-
lated for each E. coli ORF using the method in [57]. This
calculation was implemented using the codonR package (
http://people.cryst.bbk.ac.uk/~fdosr01/tAI/index.html,
downloaded on 3rd Sep 2011). mRNA folding energy was cal-
culated for the first 37nt of each E. coli ORF together with
the 5 upstream nucleotides (GTACC) in the pZS11 plasmid
backbone. Calculation was implemented using the hybrid-ss-
min command in UNAFold software v3.8 [58] with default
parameter values for reaction conditions (NA = RNA, T =
37, [Na+] = 1, [Mg++] = 0, maxloop = 30).
Supplementary notes
Use of methyl esters in amino acid limitation experiments.
Before we settled on the methyl ester analog-based experi-
ments, we tested two other amino acid limitation assays that
are commonly used in the literature. The first assay is a spin
→ wash → resuspend in amino acid+ / amino acid– medium
[10]. We did not pursue this assay for most experiments since
it is logistically difficult to perform this assay when working
simultaneously with more than a dozen strains. However, we
used this assay for the Western blotting and RT-qPCR mea-
surements on a few strains (Figs. S1, S14 and 4B).
The second assay involves starting with a low initial con-
centration of an amino acid and letting the bacterial cultures
exhaust the amino acid in the medium through exponential
growth [59]. The bacteria then enter the amino acid limited
regime in mid-log phase without any intervention from the ex-
perimenter. However in the absence of exogenous sources of
amino acid in the amino acid limited regime, protein synthe-
sis occurs only transiently for less than an hour under these
conditions and YFP synthesis rates from all yfp variants drop
below measurable levels at the end of this time period (Fig.
S15). More importantly, there is no extended steady state
during which differential protein synthesis rates can be mea-
sured accurately. Nevertheless, we have confirmed that the
measurements with and without methyl esters give qualita-
tively similar results (Fig. S16). In addition, Western blotting
done in the absence of methyl ester reproduced the heirarchy
in protein levels between synonymous variants of YFP during
amino acid limitation (Fig. S1).
In contrast to the assay without methyl ester, presence of
methyl ester analogs in the growth medium results in a quasi-
steady state of amino acid limited growth due to hydrolysis
of the ester, during which differential YFP expression can be
measured easily (Fig. S15). Such partial amino acid limited
growth is also likely to be the relevant scenario when pro-
totrophic strains run out of amino acids in their growth me-
dia and have a limited supply of amino acids through protein
degradation or partially up-regulated biosynthesis pathways.
Effect of varying the initial concentrations of amino acids
and methyl esters. Increasing the initial concentration of the
amino acid or its methyl ester results in a higher cell density
for the onset of amino acid limitation, and when the corre-
sponding concentrations are decreased, this onset happens at
a lower cell density. Importantly, the observed differential ro-
bustness of protein synthesis (such as the data shown in Fig.
1D) is qualitatively the same upon 2-fold changes to the initial
concentration of either the amino acid or its methyl ester. As
an extreme example, see Figs. S15 and S16 for comparison
between the cases with and without methyl ester analog in
the growth medium.
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Fig. S1: Expression level of yfp variants quantified through Western blotting
Modified versions of 29 yfp variants (Fig. 1A) were created that had a 3X-FLAG tag at the 5′ end. These yfp variants were
transformed into the respective E. coli auxotrophs in which YFP synthesis was repressed by the TetR protein. Cells were
harvested at an OD600 of 0.4 and re-suspended in medium with or without the corresponding amino acid. Expression of YFP
was induced using 200ng/ml anhydrotetracyline, and cells were harvested after 60 min. For each set of yfp variants under a
specific growth condition, the same amount of total protein (as measured by OD600 before cell lysis) was used for Western
blotting.
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Fig. S2: Effect of a single synonymous mutation on YFP synthesis rate
22 variants of yfp were synthesized, each of which had a single CTA codon at one of the 22 leucine codon locations along yfp.
The remaining leucine codons in each variant were the perturbation-robust CTG codon. The ‘control’ yfp variant did not have
any CTA codon. Vertical axis refers to the YFP synthesis rate from the 22 variants normalized by that of the control variant,
either during leucine limitation (top panel) or during leucine-rich growth (bottom panel). Horizontal axis indicates the location
of the CTA codon along each yfp variant (ATG start codon = 1). Error bars show standard error over three replicate cultures.
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Fig. S3: YFP synthesis rate during limitation for a non-cognate amino acid
Leucine and arginine variants of yfp were expressed in an E. coli strain, CP78, that is auxotrophic for both leucine and arginine.
Response of the 6 Leu variants to Arg limitation is determined by the Arg codons in yfp (CGT and CGC) that are common
across all 6 Leu variants. Reciprocally, the response of the 6 Arg variants to Leu limitation is determined by the Leu codon
that is common to the Arg variants of yfp (CTG). YFP synthesis rates are defined as in Fig. 1D. Error bars show standard
error over three replicate cultures.
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Fig. S4: Comparison of synthesis rate robustness with codon usage and tRNA concentration
(A) Codon usage was calculated as the average frequency of each codon across all protein coding sequences in E. coli. (B)
tRNA concentration for each codon was calculated as the sum of tRNA concentrations for all cognate tRNAs [54]. (C) Since
tRNAs can differ substantially in their affinity for their cognate codons, we also compared the measured robustness against
the tRNA adaptation index for each codon [57]. This index accounts for different affinities of synonymous codons for the same
tRNA isoacceptor. All three measures along the horizontal axes were normalized by the maximum value within each codon
family. Robustness to amino acid limitation was quantified as the ratio of normalized YFP synthesis rates between amino acid
limited and amino acid rich growth phases. Error bars represent standard error over three replicate cultures. The data points
that are not visible for a few codons overlap at the top right-hand corner of each plot.
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Fig. S5: Comparison of synthesis rate robustness with charged tRNA fraction
To compare YFP synthesis rates with charged tRNA fractions, the elongation rates for leucine and arginine codons were inferred
from the measured charged fraction of leucine and arginine tRNA isoacceptors [10] (see section on codon specific bioinformatic
measures). Previously assigned codon-tRNA assignments and kinetic parameters were used [9]. Note that charged tRNA
fractions cannot be directly compared with synthesis rates of yfp variants due to overlapping and multiple codon assignments
for several tRNA isoacceptors. Robustness to amino acid limitation was quantified as the ratio of normalized YFP synthesis
rates between amino acid limited and amino acid rich growth phases. Error bars represent standard error over three replicate
cultures. Relative codon elongation rate is the ratio of codon elongation rates between amino acid starved and amino acid rich
growth regimes, normalized to the maximum value within each synonymous codon family.
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Fig. S6: Miscoding of a single arginine residue in YFP causes loss of fluorescence
To test whether mistranslation of arginine residues can underlie the high residual fluorescence of Arg yfp variant-Arg tRNA
pairs (AGA: arg3, AGG: arg3, and CGG:arg4, arg5 in Fig. 2B), three YFP mutants were created that had one of three single
point mutations at Arg96: R96H, R96K, and R96Q. The mutant and the ‘wild-type’ YFP proteins were expressed from a
pUC18 high-copy vector. Each of the three mutations at Arg96 to a chemically similar amino acid (H, K or Q) decreased YFP
fluorescence to background level (that of an empty pUC18 vector). Error bars denote standard deviation over five biological
replicates.
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Fig. S7: Histogram of CRI
Green and purple data markers correspond to the Leu and Arg CRI values for 4300 ORFs in E. coli ’s genome. Blue and red data
markers correspond respectively to Leu and Arg CRI values for the E. coli ORF-yfp fusions that were used to experimentally
validate CRI.
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Fig. S8: Correlation of Arg CRI with measured robustness of 56 E. coli ORF-yfp fusions
The yfp sequence used for this experiment had the AGA codon at all Arg codon locations of yfp since AGA has the highest
wi value among arginine codons (see Fig. 3B). Correlation is reported as squared Spearman rank correlation. Error bars show
standard error over three replicate cultures. Robustness to amino acid limitation was quantified as the ratio of normalized YFP
synthesis rates between amino acid limited and amino acid rich growth phases.
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Fig. S9: Correlation of protein synthesis rate during amino acid rich growth with measures of translation efficiency
Protein synthesis rates from 92 E. coli ORF-yfp fusions during Leu-rich growth showed only a weak correlation with measures
of codon adaptation, tRNA adaptation and 5′ folding energy of mRNA. Folding energy was calculated from -5 to +37 nt of the
ATG codon. Codon adaptation index (CAI) and tRNA adaptation index (tAI) were calculated using Biopython and codonR
packages. Correlations are reported as squared Spearman rank-correlation coefficient.
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Fig. S10: CRI predicts the change in robustness during amino acid limitation due to synonymous mutations
Sixty three synonymous variants of 13 ORF-yfp fusions were constructed by mutating wild-type TTG or TTA codons in
the ORF sequence to the codon CTC that causes sensitive protein synthesis rate under leucine limitation. The number of
mutations was between 1 and 6 and the location of these mutations was random. 59 of the 63 variants displayed a decrease
in their robustness during Leu limitation (dashed lines) that was predicted by Leu CRI (solid lines). In addition, magnitude
of the changes in robustness during Leu limitation were positively correlated with magnitude of the changes in Leu CRI (r2
= 0.19, P = 10−4). Filled circles indicate values for ORFwild-type and open circles indicate values for ORFvariant. Different
open circles within a single polygon correspond to distinct ORF variants for the same wild-type ORF. Robustness to amino
acid limitation was quantified as the ratio of normalized YFP synthesis rates between amino acid limited and amino acid rich
growth phases. Error bars show standard error over three replicate cultures. Most error bars are smaller than data markers.
DNA sequences for variants are provided in gene sequences.fasta supplementary file.
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Fig. S11: Effect of synonymous mutations and tRNA co-expression on synthesis rate from E. coli ORF-yfp fusions
We analyzed the change in protein synthesis rates from the 21 ORF-yfp fusions co-expressed with GAGLeu2 (Fig. 3D) and
the 63 different ORF-yfp variants with synonymous mutations (Fig. S10). Several of the GAGLeu2-coexpressed as well as the
synonymously-mutated ORF-yfp variants (84 total variants) had significantly altered protein synthesis rates compared to their
non-tRNA co-expressed or non-mutated counterparts (referred as wild type) during leucine limited growth (green histogram,
median fold-change in protein synthesis rates = 2.37). By comparison, most of the 84 variants had similar protein synthesis
rates to their wild-type counterparts during leucine rich growth (grey histogram, median fold-change in protein synthesis rates
= 1.12). Protein synthesis rates were defined as in Fig. 1D.
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Fig. S12: Effect of synonymous mutations on synthesis rate from amino acid biosynthesis genes
(A) Synthesis rates from leuA, leuC, leuD and carA, argA, argF -yfp fusions encoding either wild-type or mutant ORF sequences
during amino acid rich and amino acid limited growth. The synthesis rates were normalized for each pair of wild-type and
mutant ORF-yfp fusions, and also for each growth condition. Error bars show standard error over six replicate cultures. (B)
Position and identity of synonymous mutations in wild-type and mutant sequences used for the experiment in (A). The black
vertical bars correspond to the non-mutated leucine codons in the case of leuA, leuC and leuD, and to the non-mutated arginine
codons in the case of carA, argA and argF.
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Fig. S13: Correlation of protein synthesis rate with ribosome occupancy at serine codons during serine-limited growth
Protein synthesis rate of serine synonymous variants of yfp during serine limitation (same data as in Fig. 1D, third panel)
is negatively correlated with genome-wide ribosome occupancy at serine codons during serine-limited growth of E. coli. The
increased occupancy at perturbation-sensitive serine codons is consistent with selective ribosome pausing at these codons.
Ribosome occupancy data was taken from a recent ribosome profiling experiment in E. coli [60].
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Fig. S14: Change in mRNA level of yfp variants in response to cognate amino acid limitation
We measured the change in mRNA levels of different yfp variants in response to amino acid limitation. Total RNA was
extracted either during exponential amino acid rich growth or 60 min after amino acid limited growth in the presence of the
amino acid methyl ester. mRNA levels were quantified by RT-qPCR relative to gapA mRNA. Error bars show standard error
of triplicate qPCR measurements. Synthesis rate robustness to amino acid limitation was quantified as the ratio of normalized
YFP synthesis rates between amino acid limited and amino acid rich growth phases.
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Fig. S15: Raw absorbance and fluorescence curves with or without methyl ester analog of amino acids
Growth and fluorescence curves for two yfp variants corresponding to CTA and CTG codons are shown here as representative
examples for amino acid limited growth in the presence or absence of methyl ester analogs in the growth medium. Absorbance
as measured using spectrometry is proportional to cell density. Presence of methyl ester analogs caused an increase in the time
and cell density at which amino acid limited growth began. More importantly, inefficient metabolism of methyl ester analogs
resulted in a slow but steady growth in amino acid limited regime. This residual growth ensured that YFP synthesis continued
robustly from the CTG yfp variant under these conditions. By contrast, in the absence of methyl esters in the growth medium,
YFP synthesis from all yfp variants eventually dropped to zero.
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Fig. S16: Synthesis rate robustness with or without methyl ester analog of amino acids
Robustness to amino acid limitation in the absence of methyl ester analogs was calculated as the ratio of fluorescence change
between the amino acid limited growth phase and amino acid rich growth phase. This ratio was further normalized by the
maximum value within each codon family. Robustness to amino acid limitation in the presence of methyl ester analogs was
quantified as the ratio of normalized YFP synthesis rates between amino acid limited and amino acid rich growth phases. Error
bars show standard error over three replicate cultures.
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Fig. S17: Plasmid map of expression vector for yfp and E. coli ORF-yfp fusions
A specific plasmid construct with yfp0 is shown here. In the case of ORF-yfp fusions, yfp was fused in-frame to the 3′-end
of the ORF with a GGSGGS hexa-peptide linker sequence that encoded a BamHI restriction site and the resulting coding
sequence of the fusion protein was cloned between the KpnI and HindIII restriction sites in the above vector.
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Fig. S18: Plasmid map of expression vector for tRNA genes
A specific construct encoding an Arg tRNA is shown here.
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Fig. S19: Reproducibility of measurements between biological replicates of 92 E. coli ORF-yfp fusions
Two different colonies were picked after cloning the 92 E. coli ORF-yfp fusions and the same leucine limitation assay that was
used for the data in Fig. 3C was performed on these two biological replicates on two different days. None of the clones for
replicate 2 were sequence-verified and hence the few outliers seen above could be the result of errors in the cloned sequences.
The data reported in Fig. 3C is from replicate 1 for which about 40 constructs were sequence-verified. Robustness to Leu
limitation was calculated as the ratio of normalized YFP synthesis rates between Leu limited and Leu rich growth phases.
Table S1: 92 E. coli ORF-yfp fusions used for Leu CRI validation
Genes are arranged by increasing values of Leu CRI. SLeu−rich and SLeu−limited refer to respective protein synthesis rates (a.u.
per sec per cell). Robustness refers to the ratio between the two protein synthesis rates after normalization by the corresponding
value for the CTG variant of yfp (which is the yfp tag in these ORF-yfp fusions). ± refers to standard error of measurement.
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
1 polB 10.4 ± 0.3 0.6 ± 0.6 0.063 ± 0.062 -19.45 DNA polymerase II
2 thiH 69.7 ± 1.1 -0.7 ± 0.8 -0.012 ± 0.013 -14.52 tyrosine lyase, involved in
thiamin-thiazolemoiety synthe-
sis
3 aat 26.7 ± 0.8 1.3 ± 0.3 0.054 ± 0.015 -12.52 leucyl/phenylalanyl-tRNA-
protein transferase
4 gdhA 20.4 ± 0.3 -0.2 ± 0.2 -0.013 ± 0.009 -11.62 glutamate dehydrogenase,
NADP-specific
5 serC 91.3 ± 0.5 -1.7 ± 0.6 -0.020 ± 0.008 -11.6 3-
phosphoserine/phosphohydroxy
threonine aminotransferase
6 gpsA 111.8 ± 3.3 1.9 ± 1.9 0.020 ± 0.018 -11.38 glycerol-3-phosphate dehydro-
genase (NAD+)
7 mlrA 44.1 ± 1.5 -0.7 ± 0.8 -0.017 ± 0.019 -11.09 DNA-binding transcriptional
regulator
8 ybeU 41.5 ± 7.6 0.5 ± 0.3 0.017 ± 0.013 -11 conserved protein, DUF1266
family
9 argS 67.6 ± 1.9 1.0 ± 0.6 0.017 ± 0.010 -10.93 arginyl-tRNA synthetase
10 ilvD 59.2 ± 5.6 3.4 ± 0.9 0.064 ± 0.017 -10.39 dihydroxyacid dehydratase
11 ugpC 88.5 ± 2.7 1.9 ± 0.9 0.023 ± 0.011 -10.33 glycerol-3-phosphate trans-
porter subunit
12 argI 44.5 ± 4.5 5.3 ± 2.6 0.138 ± 0.067 -10.24 ornithine carbamoyltransferase
1
13 ttdA 86.1 ± 0.2 -0.0 ± 0.5 -0.000 ± 0.006 -10.06 L-tartrate dehydratase, alpha
subunit
14 leuS 143.4 ± 3.7 -2.5 ± 0.5 -0.019 ± 0.003 -9.46 leucyl-tRNA synthetase
15 hisB 119.8 ± 3.7 -0.3 ± 3.0 -0.002 ± 0.027 -9.31 fusedhistidinol-
phosphatase/imidazoleglycerol-
phosphatedehydratase
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Table S1 (contd.): 92 E. coli ORF-yfp fusions used for Leu CRI validation
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
16 rpoA 71.8 ± 7.5 0.0 ± 0.6 -0.001 ± 0.009 -9.05 RNA polymerase, alpha subunit
17 uvrY 173.2 ± 8.8 -5.2 ± 9.3 -0.027 ± 0.061 -8.36 DNA-binding response regula-
tor in two-component regula-
tory system with BarA
18 rob 24.9 ± 0.7 0.5 ± 0.2 0.024 ± 0.007 -7.94 right oriC-binding transcrip-
tional activator,AraC family
19 agaS 73.0 ± 3.3 1.3 ± 0.4 0.019 ± 0.005 -7.48 tagatose-6-phosphate ke-
tose/aldose isomerase
20 lysS 111.8 ± 4.4 3.7 ± 2.1 0.035 ± 0.020 -7.17 lysine tRNA synthetase, consti-
tutive
21 sdaB 121.0 ± 5.7 36.4 ± 4.1 0.333 ± 0.044 -7.14 L-serine deaminase II
22 purA 35.5 ± 2.2 -1.2 ± 0.4 -0.039 ± 0.015 -7.12 adenylosuccinate synthetase
23 rpoD 77.5 ± 2.2 2.3 ± 1.1 0.032 ± 0.014 -6.99 RNA polymerase, sigma 70
(sigma D) factor
24 melR 44.5 ± 3.3 15.1 ± 0.4 0.378 ± 0.031 -6.76 DNA-binding transcriptional
dual regulator
25 kefF 99.2 ± 3.0 3.3 ± 0.5 0.038 ± 0.007 -6.52 flavoprotein subunit for the
KefC potassium efflux system
26 uhpA 22.4 ± 1.5 0.4 ± 0.7 0.019 ± 0.034 -6.5 DNA-binding response regula-
tor in two-component regula-
tory system wtih UhpB
27 ydcN 41.6 ± 2.7 1.9 ± 0.7 0.050 ± 0.015 -6.5 predicted DNA-binding tran-
scriptional regulator
28 aspS 62.3 ± 4.2 10.9 ± 1.5 0.191 ± 0.014 -6.42 aspartyl-tRNA synthetase
29 relB 87.9 ± 2.3 0.8 ± 0.9 0.009 ± 0.010 -6.09 Qin prophage; bifunctional
antitoxin of theRelE-RelB
toxin-antitoxin system/ tran-
scriptional repressor
30 guaA 122.6 ± 2.3 6.9 ± 2.2 0.061 ± 0.019 -5.81 GMP synthetase (glutamine
aminotransferase)
31 phnM 203.7 ± 9.5 20.9 ± 1.2 0.113 ± 0.007 -5.81 carbon-phosphorus lyase com-
plex subunit
32 tdcD 4.5 ± 0.4 7.1 ± 0.2 1.755 ± 0.163 -5.76 propionate kinase/acetate ki-
nase C, anaerobic
33 ompR 114.2 ± 18.7 -1.4 ± 2.2 -0.019 ± 0.027 -5.74 DNA-binding response regula-
tor in two-component regula-
tory system with EnvZ
34 phnL 75.7 ± 5.3 5.7 ± 1.1 0.082 ± 0.013 -5.51 carbon-phosphorus lyase com-
plex subunit
35 purH 29.6 ± 1.4 10.2 ± 0.4 0.383 ± 0.025 -5.27 fused IMPcyclohydrolase /
phosphoribosyl aminoimidazole
carboxamide formyltransferase
36 argG 2.5 ± 0.2 3.0 ± 0.2 1.343 ± 0.150 -5.07 argininosuccinate synthetase
37 rimM 107.5 ± 3.7 13.3 ± 0.9 0.137 ± 0.014 -4.95 16S rRNA processing protein
38 ubiC 93.6 ± 3.9 7.5 ± 2.2 0.087 ± 0.022 -4.87 chorismate–pyruvate lyase
39 leuL 48.9 ± 2.3 0.7 ± 0.5 0.017 ± 0.011 -4.75 leu operon leader peptide
40 asnS 9.0 ± 0.4 7.2 ± 0.5 0.884 ± 0.071 -4.65 asparaginyl tRNA synthetase
41 ribB 107.6 ± 7.8 12.2 ± 1.0 0.127 ± 0.020 -4.49 3,4-dihydroxy-2-butanone-4-
phosphate synthase
42 smpB 15.8 ± 0.8 1.5 ± 0.4 0.101 ± 0.023 -4.39 trans-translation protein
43 guaB 31.0 ± 0.3 5.2 ± 0.6 0.184 ± 0.022 -4.21 IMP dehydrogenase
44 proC 69.2 ± 3.1 9.4 ± 1.6 0.151 ± 0.030 -3.92 pyrroline-5-carboxylate
reductase,NAD(P)-binding
45 pth 89.0 ± 2.6 25.2 ± 0.9 0.313 ± 0.018 -3.1 peptidyl-tRNA hydrolase
46 ivbL 1.8 ± 0.3 1.6 ± 0.1 1.085 ± 0.295 -2.89 ilvB operon leader peptide
47 chbR 25.6 ± 1.0 24.4 ± 0.8 1.054 ± 0.008 -2.81 rRepressor, chb operon forN,N’-
diacetylchitobiose utilization
48 leuA 78.1 ± 2.2 53.6 ± 0.8 0.756 ± 0.019 -2.77 2-isopropylmalate synthase
49 argD 85.7 ± 4.4 51.0 ± 1.8 0.657 ± 0.031 -2.72 bifunctional acetylor-
nithine aminotrans-
ferase/succinyldiaminopimelate
aminotransferase
50 yfcN 98.8 ± 2.1 24.2 ± 1.5 0.270 ± 0.011 -2.71 conserved protein
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Table S1 (contd.): 92 E. coli ORF-yfp fusions used for Leu CRI validation
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
51 ygiD 7.3 ± 0.3 9.9 ± 0.4 1.503 ± 0.046 -2.62 predicted dioxygenase, LigB
family
52 mdtJ 12.5 ± 1.6 17.5 ± 0.2 1.595 ± 0.204 -2.52 multidrug efflux system trans-
porter
53 agaR 80.6 ± 2.5 31.4 ± 2.0 0.428 ± 0.018 -2.39 DNA-binding transcriptional
repressor of the aga regulon
54 hisA 22.0 ± 0.9 27.6 ± 0.9 1.392 ± 0.087 -1.86 N-(5’-phospho-L-ribosyl-
formimino)-5-amino-1-
(5’-phosphoribosyl)-4-
imidazolecarb oxamide iso-
merase
55 ygbF 72.7 ± 21.5 26.4 ± 1.3 0.475 ± 0.130 -1.65 probable ssRNA endonuclease,
CRISP-associatedprotein
56 rpoH 89.2 ± 1.8 50.5 ± 0.9 0.623 ± 0.005 -1.53 RNA polymerase, sigma 32
(sigma H) factor
57 leuD 128.4 ± 2.7 70.0 ± 0.6 0.601 ± 0.018 -1.48 3-isopropylmalate dehydratase
small subunit
58 dinJ 58.9 ± 2.8 34.4 ± 1.5 0.648 ± 0.050 -1.48 antitoxin of YafQ-DinJ toxin-
antitoxin system
59 nuoI 25.2 ± 1.8 30.6 ± 1.4 1.361 ± 0.164 -1.48 NADH:ubiquinone oxidoreduc-
tase, chain I
60 luxS 109.5 ± 0.7 70.3 ± 3.9 0.706 ± 0.035 -1.34 S-ribosylhomocysteine lyase
61 leuC 104.5 ± 6.0 54.0 ± 3.4 0.573 ± 0.069 -1.18 3-isopropylmalate dehydratase
large subunit
62 pspA 69.8 ± 2.6 51.4 ± 0.6 0.813 ± 0.039 -1.18 regulatory protein for phage-
shock-proteinoperon
63 pyrI 138.9 ± 13.7 112.5 ± 6.2 0.906 ± 0.091 -1.15 aspartate carbamoyltransferase,
regulatorysubunit
64 btuE 149.1 ± 4.6 132.9 ± 3.6 0.982 ± 0.020 -0.95 glutathione peroxidase
65 msrB 153.6 ± 14.7 131.7 ± 2.8 0.958 ± 0.074 -0.8 methionine sulfoxide reductase
B
66 coaD 94.4 ± 0.3 96.2 ± 0.8 1.122 ± 0.012 -0.71 pantetheine-phosphate adeny-
lyltransferase
67 sfsB 72.2 ± 2.4 18.9 ± 1.5 0.291 ± 0.032 -0.61 DNA-binding transcriptional
activator of maltosemetabolism
68 nirD 113.2 ± 17.8 22.1 ± 1.5 0.223 ± 0.027 -0.52 nitrite reductase, NAD(P)H-
binding, smallsubunit
69 fdnI 62.4 ± 1.6 57.8 ± 3.4 1.019 ± 0.034 -0.43 formate dehydrogenase-
N, cytochrome B556
(gamma)subunit, nitrate-
inducible
70 greA 172.5 ± 12.4 90.0 ± 1.2 0.581 ± 0.045 -0.38 transcript cleavage factor
71 hupB 287.5 ± 19.6 116.5 ± 4.0 0.450 ± 0.030 -0.33 HU, DNA-binding transcrip-
tional regulator, betasubunit
72 glpE 144.2 ± 2.0 142.0 ± 2.6 1.086 ± 0.035 -0.33 thiosulfate:cyanide sulfurtrans-
ferase(rhodanese)
73 ogrK 95.8 ± 9.5 145.2 ± 3.3 1.699 ± 0.153 -0.33 positive regulator of P2 growth
(insertion of P2ogr gene into the
chromosome)
74 rplD 20.9 ± 1.5 41.0 ± 1.6 2.191 ± 0.226 -0.33 50S ribosomal subunit protein
L4
75 dmsB 116.2 ± 5.3 156.3 ± 5.1 1.486 ± 0.067 -0.28 dimethyl sulfoxide reductase,
anaerobic, subunitB
76 rpsP 241.7 ± 3.7 118.5 ± 0.3 0.540 ± 0.007 -0.19 30S ribosomal subunit protein
S16
77 rplX 150.6 ± 3.2 83.7 ± 3.5 0.613 ± 0.031 -0.19 50S ribosomal subunit protein
L24
78 tpiA 138.5 ± 11.4 87.1 ± 2.2 0.700 ± 0.047 -0.19 triosephosphate isomerase
79 gapA 39.5 ± 2.0 62.6 ± 1.6 1.757 ± 0.135 -0.19 glyceraldehyde-3-phosphate de-
hydrogenase A
80 rpsT 174.7 ± 12.0 133.7 ± 4.5 0.849 ± 0.050 -0.14 30S ribosomal subunit protein
S20
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Table S1 (contd.): 92 E. coli ORF-yfp fusions used for Leu CRI validation
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
81 rpsJ 170.2 ± 37.2 142.3 ± 1.6 1.015 ± 0.219 -0.14 30S ribosomal subunit protein
S10
82 rplT 120.5 ± 8.5 112.6 ± 3.7 1.039 ± 0.077 -0.14 50S ribosomal subunit protein
L20
83 ahpC 57.0 ± 5.0 64.9 ± 1.7 1.267 ± 0.078 -0.14 alkyl hydroperoxide reductase,
C22 subunit
84 rpsK 109.9 ± 9.2 139.0 ± 3.5 1.411 ± 0.113 -0.14 30S ribosomal subunit protein
S11
85 tsf 200.4 ± 2.8 103.8 ± 2.1 0.570 ± 0.008 0 protein chain elongation factor
EF-Ts
86 rplU 173.3 ± 12.4 92.5 ± 4.9 0.595 ± 0.056 0 50S ribosomal subunit protein
L21
87 rpmI 158.7 ± 4.0 104.2 ± 1.4 0.725 ± 0.025 0 50S ribosomal subunit protein
L35
88 yjgF 131.9 ± 5.3 98.1 ± 3.0 0.824 ± 0.057 0 conserved protein, UPF0131
family
89 ppiB 133.6 ± 4.5 114.6 ± 2.7 0.945 ± 0.011 0 peptidyl-prolyl cis-trans iso-
merase B (rotamaseB)
90 yjbJ 134.6 ± 4.4 158.7 ± 1.1 1.300 ± 0.035 0 conserved protein, UPF0337
family
91 rpsI 27.5 ± 2.8 78.6 ± 6.0 3.198 ± 0.324 0 30S ribosomal subunit protein
S9
92 rpsF 31.7 ± 1.6 97.1 ± 0.8 3.392 ± 0.183 0 30S ribosomal subunit protein
S6
Table S2: 56 E. coli ORF-yfp fusions used for Arg CRI validation
Genes are arranged by increasing values of Arg CRI. SArg−rich and SArg−limited refer to respective protein synthesis rates (a.u.
per sec per cell). Robustness refers to the ratio between the two protein synthesis rates after normalization by the corresponding
value for the AGA variant of yfp (this AGA variant was also used as the yfp tag in these ORF-yfp fusions). ± refers to standard
error of measurement.
Number Gene SArg−rich SArg−limited Robustness log2(Arg CRI) Gene product
1 leuS 100.5 ± 2.6 16.1 ± 1.7 0.107 ± 0.012 -10.05 leucyl-tRNA synthetase
2 phoR 16.4 ± 3.2 0.7 ± 0.6 0.027 ± 0.029 -8.52 sensory histidine kinase in two-
componentregulatory system
with PhoB
3 glnG 61.0 ± 3.4 10.8 ± 2.3 0.118 ± 0.022 -8.51 fused DNA-binding response
regulator intwo-component reg-
ulatory system with GlnL: re-
sponseregulator/sigma54 inter-
action protein
4 asnS 15.5 ± 1.8 2.6 ± 0.1 0.114 ± 0.014 -8.38 asparaginyl tRNA synthetase
5 guaA 91.5 ± 4.2 11.7 ± 3.7 0.083 ± 0.024 -8.25 GMP synthetase (glutamine
aminotransferase)
6 thiH 53.9 ± 1.1 4.4 ± 1.3 0.054 ± 0.015 -7.16 tyrosine lyase, involved in
thiamin-thiazolemoiety synthe-
sis
7 fruR 44.7 ± 1.5 5.3 ± 0.1 0.079 ± 0.004 -6.54 DNA-binding transcriptional
dual regulator
8 argG 10.0 ± 0.9 2.5 ± 1.1 0.175 ± 0.088 -6.49 argininosuccinate synthetase
9 gpsA 81.9 ± 3.9 9.1 ± 4.2 0.073 ± 0.032 -5.81 glycerol-3-phosphate dehydro-
genase (NAD+)
10 rpoA 60.9 ± 1.6 10.5 ± 2.1 0.114 ± 0.022 -5.36 RNA polymerase, alpha subunit
11 yiiD 31.2 ± 1.8 9.8 ± 2.9 0.218 ± 0.078 -5.05 predicted acetyltransferase
12 agaR 53.2 ± 1.8 2.6 ± 0.8 0.032 ± 0.010 -5.01 DNA-binding transcriptional
repressor of the agaregulon
13 rimK 17.9 ± 2.6 9.8 ± 1.5 0.393 ± 0.106 -4.94 ribosomal protein S6 modifica-
tion protein
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Table S2 (contd.): 56 E. coli ORF-yfp fusions used for Arg CRI validation
Number Gene SArg−rich SArg−limited Robustness log2(Arg CRI) Gene product
14 rpoH 75.2 ± 2.8 9.3 ± 2.9 0.081 ± 0.023 -4.76 RNA polymerase, sigma 32
(sigma H) factor
15 melR 43.7 ± 0.4 11.1 ± 2.3 0.170 ± 0.036 -4.46 DNA-binding transcriptional
dual regulator
16 tdcB 32.1 ± 2.0 10.2 ± 2.9 0.208 ± 0.051 -3.83 catabolic threonine dehy-
dratase, PLP-dependent
17 serC 68.2 ± 2.3 28.9 ± 4.2 0.284 ± 0.043 -3.79 3-
phosphoserine/phosphohydroxy
threonine aminotransferase
18 rnc 65.7 ± 2.5 15.4 ± 2.6 0.157 ± 0.028 -3.74 RNase III
19 chbR 22.3 ± 1.2 6.2 ± 2.1 0.190 ± 0.064 -3.66 rRepressor, chb operon forN,N’-
diacetylchitobiose utilization
20 rsuA 100.3 ± 5.9 12.8 ± 2.8 0.084 ± 0.015 -3.65 16S rRNA U516 pseudouridine
synthase
21 tauC 70.1 ± 3.2 7.4 ± 1.3 0.071 ± 0.016 -3.5 taurine transporter subunit
22 smpB 55.3 ± 1.3 17.5 ± 0.8 0.211 ± 0.010 -3.42 trans-translation protein
23 carA 28.2 ± 1.1 14.0 ± 0.8 0.331 ± 0.005 -3.4 carbamoyl phosphate syn-
thetase small subunit,glutamine
amidotransferase
24 ubiC 70.6 ± 1.8 4.7 ± 1.9 0.044 ± 0.018 -3.39 chorismate–pyruvate lyase
25 pth 71.2 ± 2.4 20.0 ± 0.8 0.187 ± 0.001 -3.21 peptidyl-tRNA hydrolase
26 rpsF 26.6 ± 1.9 14.7 ± 2.3 0.366 ± 0.043 -3.06 30S ribosomal subunit protein
S6
27 gapA 34.3 ± 0.9 12.1 ± 1.9 0.234 ± 0.030 -2.86 glyceraldehyde-3-phosphate de-
hydrogenase A
28 yihL 43.2 ± 3.4 6.7 ± 1.1 0.105 ± 0.022 -2.85 predicted DNA-binding tran-
scriptional regulator
29 allR 36.0 ± 1.5 17.1 ± 0.8 0.318 ± 0.026 -2.82 DNA-binding transcriptional
repressor for all(allantoin)
and gcl (glyoxylate)
operons;glyoxylate-induced
30 yfcN 74.2 ± 4.8 38.9 ± 7.3 0.353 ± 0.068 -2.8 conserved protein
31 fdnI 42.7 ± 1.8 17.8 ± 3.2 0.277 ± 0.042 -2.65 formate dehydrogenase-
N, cytochrome B556
(gamma)subunit, nitrate-
inducible
32 ruvA 53.2 ± 4.1 26.7 ± 1.1 0.341 ± 0.040 -2.59 component of RuvABC resolva-
some, regulatorysubunit
33 adiY 47.5 ± 8.2 6.1 ± 0.9 0.086 ± 0.003 -2.55 DNA-binding transcriptional
activator
34 holD 15.1 ± 3.6 2.9 ± 1.3 0.153 ± 0.066 -2.43 DNA polymerase III, psi sub-
unit
35 dmsB 68.1 ± 2.2 54.7 ± 6.5 0.537 ± 0.067 -2.42 dimethyl sulfoxide reductase,
anaerobic, subunitB
36 bglJ 10.5 ± 1.3 6.6 ± 0.7 0.420 ± 0.010 -2.39 DNA-binding transcriptional
activator for silentbgl operon,
requires the bglJ4 allele to
function; LuxRfamily
37 yfdT 71.4 ± 1.4 17.6 ± 0.7 0.164 ± 0.005 -2.32 CPS-53 (KpLE1) prophage;
predicted protein
38 argF 64.9 ± 2.8 35.7 ± 2.5 0.371 ± 0.044 -2.01 ornithine carbamoyltransferase
2, chain F; CP4-6prophage
39 rplU 102.0 ± 7.4 20.5 ± 4.2 0.134 ± 0.029 -1.89 50S ribosomal subunit protein
L21
40 luxS 90.3 ± 1.4 54.9 ± 2.4 0.406 ± 0.018 -1.77 S-ribosylhomocysteine lyase
41 coaD 70.9 ± 1.5 45.3 ± 3.4 0.426 ± 0.036 -1.75 pantetheine-phosphate adeny-
lyltransferase
42 glnB 199.0 ± 6.0 61.9 ± 7.2 0.207 ± 0.021 -1.75 regulatory protein P-II for glu-
taminesynthetase
43 uidR 32.2 ± 1.7 35.7 ± 1.5 0.745 ± 0.064 -1.5 DNA-binding transcriptional
repressor
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Table S2 (contd.): 56 E. coli ORF-yfp fusions used for Arg CRI validation
Number Gene SArg−rich SArg−limited Robustness log2(Arg CRI) Gene product
44 relB 69.6 ± 4.3 29.8 ± 0.5 0.287 ± 0.016 -1.35 Qin prophage; bifunctional
antitoxin of theRelE-RelB
toxin-antitoxin system/ tran-
scriptionalrepressor
45 btuE 106.1 ± 1.4 52.7 ± 4.0 0.331 ± 0.021 -1.35 glutathione peroxidase
46 argR 37.3 ± 3.4 13.7 ± 4.4 0.235 ± 0.054 -1.19 DNA-binding transcriptional
dual regulator,L-arginine-
binding
47 ogrK 53.3 ± 1.5 29.3 ± 0.9 0.367 ± 0.013 -1.14 positive regulator of P2 growth
(insertion of P2ogr gene into the
chromosome)
48 hupB 127.5 ± 3.6 71.2 ± 1.0 0.373 ± 0.008 -1.13 HU, DNA-binding transcrip-
tional regulator, betasubunit
49 ppiB 95.0 ± 2.7 57.2 ± 10.5 0.401 ± 0.069 -1.13 peptidyl-prolyl cis-trans iso-
merase B (rotamaseB)
50 yjgF 92.2 ± 4.7 74.4 ± 3.6 0.540 ± 0.032 -1.13 conserved protein, UPF0131
family
51 kefF 68.6 ± 2.5 69.7 ± 7.6 0.677 ± 0.058 -1.11 flavoprotein subunit for the
KefC potassiumefflux system
52 yjbJ 92.0 ± 5.1 96.6 ± 30.0 0.730 ± 0.272 -1.02 conserved protein, UPF0337
family
53 leuL 36.7 ± 1.4 31.8 ± 2.2 0.577 ± 0.023 -0.97 leu operon leader peptide
54 rimM 86.4 ± 1.7 89.9 ± 3.3 0.694 ± 0.029 -0.82 16S rRNA processing protein
55 ydjO 9.9 ± 0.9 20.7 ± 1.6 1.432 ± 0.219 -0.74 predicted protein
56 mdtJ 21.0 ± 0.4 26.4 ± 1.5 0.841 ± 0.060 -0.41 multidrug efflux system trans-
porter
Table S3: 21 E. coli ORF-yfp fusions co-expressed with GAGLeu2 tRNA
Genes are arranged by increasing values of Leu CRI as calculated for GAGLeu2 tRNA co-expression. SLeu−rich and SLeu−limited
refer to respective protein synthesis rates (a.u. per sec per cell) under GAGLeu2 tRNA co-expression. Robustness refers to
the ratio between the two protein synthesis rates after normalization by the corresponding value for the CTG variant of yfp
(see Fig. 1D). ± refers to standard error of measurement. Refer to Table S1 for corresponding values without GAGLeu2 tRNA
co-expression.
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
1 ygiD 8.2 ± 0.6 3.8 ± 0.8 0.515 ± 0.103 -5.69 predicted dioxygenase, LigB
family
2 chbR 26.5 ± 2.5 7.3 ± 1.5 0.299 ± 0.043 -5.68 rRepressor, chb operon forN,N’-
diacetylchitobiose utilization
3 yfcN 92.7 ± 2.6 12.1 ± 2.9 0.142 ± 0.030 -5.47 conserved protein
4 mdtJ 12.7 ± 0.8 5.7 ± 1.7 0.513 ± 0.165 -4.46 multidrug efflux system trans-
porter
5 ilvD 62.5 ± 1.5 23.6 ± 0.8 0.417 ± 0.022 -4.29 dihydroxyacid dehydratase
6 aspS 54.1 ± 2.0 18.5 ± 1.8 0.379 ± 0.046 -4.24 aspartyl-tRNA synthetase
7 lysS 106.3 ± 4.7 35.2 ± 0.8 0.367 ± 0.025 -4.22 lysine tRNA synthetase, consti-
tutive
8 leuC 100.7 ± 0.5 19.0 ± 1.7 0.208 ± 0.019 -4.04 3-isopropylmalate dehydratase
large subunit
9 ygbF 69.4 ± 3.4 8.1 ± 0.4 0.129 ± 0.009 -3.99 probable ssRNA endonuclease,
CRISP-associated protein
10 pspA 65.1 ± 1.2 25.9 ± 2.0 0.437 ± 0.025 -3.91 regulatory protein for phage-
shock-protein operon
11 guaA 122.0 ± 2.8 51.1 ± 1.9 0.462 ± 0.018 -3.27 GMP synthetase (glutamine
aminotransferase)
12 btuE 137.7 ± 4.6 57.5 ± 3.9 0.462 ± 0.044 -3.23 glutathione peroxidase
13 purA 73.3 ± 1.8 34.8 ± 2.7 0.522 ± 0.035 -3.16 adenylosuccinate synthetase
14 ompR 116.4 ± 1.0 50.7 ± 3.2 0.479 ± 0.027 -2.86 DNA-binding response regula-
tor in two-component regula-
tory system with EnvZ
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Table S3 (contd.): 21 E. coli ORF-yfp fusions co-expressed with GAGLeu2 tRNA
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI) Gene product
15 phnM 68.2 ± 4.4 48.4 ± 1.4 0.786 ± 0.044 -2.72 carbon-phosphorus lyase com-
plex subunit
16 msrB 113.4 ± 3.1 37.9 ± 2.1 0.370 ± 0.028 -2.68 methionine sulfoxide reductase
B
17 purH 71.4 ± 1.3 7.9 ± 2.0 0.120 ± 0.028 -2.61 fused IMPcyclohydro-
lase/phosphoribosyl aminoim-
idazole carboxamide formyl-
transferase
18 coaD 98.3 ± 7.4 46.7 ± 1.9 0.526 ± 0.018 -2.58 pantetheine-phosphate adeny-
lyltransferase
19 rimM 114.3 ± 5.9 51.3 ± 1.1 0.498 ± 0.030 -1.99 16S rRNA processing protein
20 relB 79.9 ± 3.0 66.6 ± 3.3 0.923 ± 0.077 -1.73 Qin prophage; bifunctional
antitoxin of theRelE-RelB
toxin-antitoxin system/ tran-
scriptional repressor
21 proC 78.1 ± 2.0 36.7 ± 4.4 0.519 ± 0.070 -1.72 pyrroline-5-carboxylate
reductase,NAD(P)-binding
Table S4: 63 synonymous mutants of 13 E. coli ORF-yfp fusions
SLeu−rich and SLeu−limited refer to respective protein synthesis rates (a.u. per sec per cell) of mutant ORFs. Robustness refers
to the ratio between the two protein synthesis rates after normalization by the corresponding value for the CTG variant of yfp
(see Fig. 1D). ± refers to standard error of measurement. Refer to Table S1 for corresponding values of wild-type ORFs. The
DNA sequence of the mutant variants below is provided in the gene sequences.fasta file. Three of the sequences below did not
have any mutations compared to the wild-type ORF and were included as internal controls.
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI)
1 btuE-yfp mutant 1 137.0 ± 5.3 50.1 ± 1.1 0.403 ± 0.007 -2.22
2 btuE-yfp mutant 4 131.5 ± 3.5 20.5 ± 0.5 0.172 ± 0.009 -3.06
3 btuE-yfp mutant 5 138.9 ± 1.8 34.1 ± 0.1 0.270 ± 0.003 -2.62
4 btuE-yfp mutant 7 123.4 ± 4.9 48.2 ± 1.8 0.433 ± 0.032 -2.22
5 btuE-yfp mutant 8 130.7 ± 5.2 28.8 ± 0.9 0.243 ± 0.015 -3.06
6 btuE-yfp mutant 9 128.9 ± 0.9 40.0 ± 0.6 0.342 ± 0.003 -2.62
7 chbR-yfp mutant 1 29.5 ± 1.7 17.7 ± 0.3 0.663 ± 0.028 -2.81
8 chbR-yfp mutant 2 26.7 ± 2.2 15.1 ± 0.4 0.634 ± 0.072 -3.25
9 chbR-yfp mutant 3 31.7 ± 0.9 11.3 ± 0.6 0.393 ± 0.029 -5.31
10 chbR-yfp mutant 4 36.0 ± 2.5 9.0 ± 0.3 0.279 ± 0.027 -6.2
11 chbR-yfp mutant 5 28.9 ± 2.4 10.7 ± 0.2 0.414 ± 0.033 -5.76
12 chbR-yfp mutant 6 32.6 ± 2.7 5.7 ± 0.5 0.197 ± 0.021 -7.03
13 chbR-yfp mutant 7 32.1 ± 1.2 7.7 ± 0.5 0.267 ± 0.023 -5.8
14 chbR-yfp mutant 9 31.3 ± 0.9 7.9 ± 0.5 0.278 ± 0.026 -6.64
15 coaD-yfp mutant 1 92.3 ± 1.3 39.1 ± 1.3 0.467 ± 0.021 -1.89
16 coaD-yfp mutant 2 91.7 ± 4.1 55.5 ± 0.8 0.669 ± 0.034 -1.1
17 coaD-yfp mutant 3 94.0 ± 2.4 47.7 ± 2.3 0.558 ± 0.014 -1.5
18 leuA-yfp mutant 6 70.5 ± 2.1 11.3 ± 0.3 0.177 ± 0.010 -4.4
19 leuA-yfp mutant 8 77.9 ± 2.2 6.6 ± 1.4 0.093 ± 0.020 -5.23
20 leuA-yfp mutant 9 70.0 ± 2.1 8.4 ± 0.2 0.132 ± 0.007 -4.84
21 leuB-yfp mutant 7 273.5 ± 8.7 6.1 ± 0.9 0.025 ± 0.003 -4.81
22 leuB-yfp mutant 8 273.3 ± 10.6 9.6 ± 1.0 0.039 ± 0.005 -4.02
23 leuB-yfp mutant 9 274.9 ± 8.1 8.4 ± 1.7 0.034 ± 0.007 -3.97
24 leuC-yfp mutant 5 86.8 ± 0.6 8.5 ± 1.7 0.108 ± 0.021 -3.64
25 leuC-yfp mutant 7 95.6 ± 1.9 5.1 ± 1.7 0.059 ± 0.019 -3.3
26 leuC-yfp mutant 8 100.5 ± 1.7 4.3 ± 0.9 0.047 ± 0.009 -3.69
27 leuC-yfp mutant 9 80.0 ± 4.9 14.3 ± 0.8 0.198 ± 0.013 -3.25
28 leuD-yfp mutant 2 123.6 ± 0.9 18.3 ± 1.2 0.163 ± 0.011 -2.76
29 leuD-yfp mutant 3 123.1 ± 3.7 39.5 ± 1.0 0.355 ± 0.020 -1.48
30 leuD-yfp mutant 4 122.0 ± 1.0 32.9 ± 0.3 0.297 ± 0.002 -1.92
31 mdtJ-yfp mutant 1 17.3 ± 0.6 9.1 ± 0.4 0.580 ± 0.020 -4.15
32 mdtJ-yfp mutant 2 12.2 ± 0.5 5.8 ± 0.3 0.520 ± 0.008 -3.31
33 mdtJ-yfp mutant 4 10.0 ± 0.9 4.3 ± 0.1 0.475 ± 0.047 -4.54
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Table S4 (contd.): 63 synonymous mutants of 13 E. coli ORF-yfp fusions
Number Gene SLeu−rich SLeu−limited Robustness log2(Leu CRI)
34 mdtJ-yfp mutant 5 13.6 ± 2.1 11.4 ± 0.5 0.979 ± 0.190 -4.15
35 mdtJ-yfp mutant 6 6.4 ± 0.9 5.1 ± 0.1 0.903 ± 0.125 -3.75
36 mdtJ-yfp mutant 7 5.9 ± 3.1 4.3 ± 0.3 1.251 ± 0.488 -4.15
37 mdtJ-yfp mutant 8 10.2 ± 1.5 8.3 ± 0.1 0.932 ± 0.117 -4.19
38 mdtJ-yfp mutant 9 10.3 ± 0.8 9.6 ± 0.2 1.049 ± 0.087 -3.36
39 msrB-yfp mutant 1 76.6 ± 1.9 23.7 ± 0.8 0.342 ± 0.014 -2.48
40 msrB-yfp mutant 2 65.3 ± 1.6 20.7 ± 0.8 0.348 ± 0.005 -2.92
41 msrB-yfp mutant 3 99.1 ± 2.7 27.8 ± 2.5 0.310 ± 0.031 -2.52
42 msrB-yfp mutant 4 94.0 ± 1.5 36.2 ± 0.4 0.424 ± 0.005 -2.08
43 pspA-yfp mutant 1 68.2 ± 1.9 16.3 ± 0.6 0.264 ± 0.006 -2.81
44 pspA-yfp mutant 2 64.2 ± 0.5 15.0 ± 0.7 0.257 ± 0.011 -2.85
45 pspA-yfp mutant 3 62.3 ± 1.5 28.5 ± 0.6 0.505 ± 0.016 -1.97
46 pspA-yfp mutant 5 73.3 ± 1.3 14.0 ± 0.9 0.211 ± 0.018 -3.2
47 pspA-yfp mutant 6 70.1 ± 3.0 18.3 ± 0.9 0.288 ± 0.013 -2.76
48 pspA-yfp mutant 7 73.5 ± 1.4 8.5 ± 0.2 0.127 ± 0.002 -3.64
49 pspA-yfp mutant 8 73.0 ± 1.2 12.3 ± 0.8 0.185 ± 0.012 -3.25
50 yfcN-yfp mutant 1 103.0 ± 3.5 8.3 ± 1.3 0.088 ± 0.012 -4.82
51 yfcN-yfp mutant 5 86.0 ± 3.6 14.9 ± 1.7 0.192 ± 0.022 -3.1
52 yfcN-yfp mutant 6 90.5 ± 1.6 5.6 ± 0.7 0.069 ± 0.009 -5.31
53 yfcN-yfp mutant 8 91.5 ± 4.1 14.1 ± 1.7 0.170 ± 0.017 -2.71
54 yfcN-yfp mutant 9 85.5 ± 1.1 5.2 ± 0.4 0.067 ± 0.005 -4.87
55 ygbF-yfp mutant 2 80.6 ± 2.6 6.2 ± 0.3 0.085 ± 0.006 -3.28
56 ygbF-yfp mutant 3 68.5 ± 3.9 25.4 ± 1.4 0.413 ± 0.044 -1.65
57 ygbF-yfp mutant 5 79.0 ± 4.1 25.1 ± 0.2 0.352 ± 0.017 -2.1
58 ygbF-yfp mutant 6 65.3 ± 2.9 10.8 ± 0.6 0.183 ± 0.019 -2.44
59 ygbF-yfp mutant 7 80.5 ± 4.0 8.3 ± 0.2 0.113 ± 0.004 -3.33
60 ygbF-yfp mutant 8 70.4 ± 3.1 10.8 ± 0.9 0.170 ± 0.019 -2.89
61 ygiD-yfp mutant 1 11.0 ± 1.0 2.1 ± 0.2 0.216 ± 0.009 -5.17
62 ygiD-yfp mutant 3 11.3 ± 0.9 4.2 ± 0.3 0.417 ± 0.056 -4.73
63 ygiD-yfp mutant 4 10.6 ± 0.5 5.4 ± 0.6 0.572 ± 0.090 -4.34
64 ygiD-yfp mutant 5 7.2 ± 1.1 3.3 ± 0.5 0.514 ± 0.041 -5.17
65 ygiD-yfp mutant 6 6.8 ± 1.2 2.7 ± 0.6 0.476 ± 0.131 -4.29
66 ygiD-yfp mutant 7 12.3 ± 2.5 2.7 ± 0.4 0.251 ± 0.016 -6.06
Table S5: List of strains
Limiting AA Strain designation CGSC number Genotype
Leu, Arg CP78 4695 W3110, argH - leuB - thr - his- thi-
Ser JW2880-1 10234 BW25113, ∆serA
Pro JW0233-2 8468 BW25113, ∆proA
Ile JW3745-2 10733 BW25113, ∆ilvA
Gln JW3841-1 10775 BW25113, ∆glnA
Phe JW2580-1 10048 BW25113, ∆pheA
- MG1655 6300 wild-type strain with known genome sequence
Table S6: Concentration of amino acids and methyl esters used for amino acid limitation experiments
Amino Acid Amino acid concen-
tration in overnight
cultures (µM)
Amino acid concen-
tration for amino
acid limitation exper-
iments (µM)
Amino acid methyl es-
ter concentration for
amino acid limitation
experiments (µM)
Catalog number for
amino acid methyl es-
ter
Leu 800 100 160 L1002 (Sigma)
Arg 800 150 160 11030 (Sigma)
Ser 10000 5000 800 412201 (Sigma)
Pro 800 0 160 287067 (Sigma)
Ile 800 100 160 I0522 (VWR)
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Table S6 (contd.): Concentration of amino acids and methyl esters used for amino acid limitation experiments
Amino Acid Amino acid concen-
tration in overnight
cultures (µM)
Amino acid concen-
tration for amino
acid limitation exper-
iments (µM)
Amino acid methyl es-
ter concentration for
amino acid limitation
experiments (µM)
Catalog number for
amino acid methyl es-
ter
Gln 800 400 400 68604 (Astatech)
Phe 800 50 50 P17202 (Sigma)
Table S7: wi values for Leu codons under
GAGLeu2 co-expression
Codon - log wi (with
GAGLeu2 co-expression)
CTA 0.48
CTC 0.05
CTG 0.04
CTT 0.02
TTA 0.26
TTG 0.33
Table S8: qPCR primer sequences
Gene Forward primer Reverse Primer
yfp TCATGCTGTTTCATGTGATC AGGGTGATGCTACTTATGGC
gapA GCTGAAGGCGAAATGAAAGG GTACCAGGATACCAGTTTCACG
rpoD TGAAGCGAACTTACGTCTGG AGAACTTGTAACCACGGCG
rpoS TCTCAACATACGCAACCTGG AGCTTATGGGACAACTCACG
rpoH TCGTAATTATGCGGGCTATGG CAGTGAACGGCGAAGGAG
rpoE CCAGAAGGGAGATCAGAAAGC TACCACATCGGGAACATCAC
rpoN TGATCCAACTCTCCCAATTCG TCGTGATTGGCTAACAGATCG
fecI ACTACCACAGCTTCCTTAACG TTTCGCTGACCATTACCCG
fliA CGCTATGCTGGATGAACTTCG CTAAACGTTCCGCTACCTCAG
leuA GTCGCTAACTACAACGGTCG GCACGCCAGATATTGTTCAG
ilvM GTTTCCACGTCTGCTCAATG CTGACTAAACAGTAAGTCGACCG
ilvB TGAGTTTCCGTGTCCAATCC ATCTGATGCTGACCAACGTC
Table S9: Codon–tRNA assignments
tRNA Unmodified Anticodon Modified Anticodon (if known) Cognate Codons Reference
Leu1 CAG - CUG [54]
Leu2 GAG - CUC, CUU [54]
Leu3 UAG cmo5UAG CUA, CUG, CUU [16]
Leu4 CAA CmAA UUA, UUG [54, 61]
Leu5 UAA cmnm5UmAA UUA, UUG [54, 61]
Arg2 ACG ICG CGU, CGC, CGA [54, 61]
Arg3 CCG - CGG [54]
Arg4 UCU mnm5UCU AGA, AGG [9, 61]
Arg5 CCU - AGG [54]
Ser1 UGA cmo5UGA UCA, UCU, UCG [54, 61]
Ser2 CGA - UCG [54]
Ser3 GCU - AGC, AGU [54]
Ser5 GGA - UCC, UCU [54]
Pro1 CGG - CCG [54]
Pro2 GGG - CCC, CCU [54]
Pro3 UGG cmo5UGG CCA, CCU, CCG [54, 61]
Ile1 GAU - AUC, AUU [54]
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Table S9 (contd.): Codon–tRNA assignments
tRNA Unmodified Anticodon Modified Anticodon (if known) Cognate Codons Reference
Ile2 CAU k2CAU AUA [54, 61]
Gln1 UUG mnm5s2UUG CAA, CAG [54, 61]
Gln2 CUG - CAG [54]
Phe GAA - UUC, UUU [54]
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